This report highlights different factors and opportunities prevailing in the “Global Age-related Vision Dysfunction Market (2024 Edition)”. According to the report, the Global Age-related Vision Dysfunction Market was valued at USD 90.12 billion and is expected to grow at a CAGR of 4.7% during 2025-2030.
The report explores a multi-faceted opportunity landscape in terms of market segmentation by Drug (Eylea, Lucentis, Combigan, Beovu and Other Drugs), By Dysfunction Type (Glaucoma, Cataract, Presbyopia and AMD) and By Distribution Channel (Online Pharmacies and Retail Pharmacies)
One of the primary drivers of the Age-related Vision Dysfunction market is the rising prevalence of age-related eye diseases. As the global population ages, the incidence of conditions like AMD, cataracts, and glaucoma increases, leading to greater demand for medical interventions. The growing awareness of these conditions and the importance of regular eye exams have also contributed to market growth, as early detection and treatment can prevent or slow the progression of vision loss.
The increasing focus on innovative treatment options and the development of advanced diagnostic technologies have significantly influenced the market. New therapies, such as anti-VEGF injections for AMD and minimally invasive glaucoma surgeries, offer improved outcomes and fewer side effects. Additionally, advancements in imaging technologies, like optical coherence tomography (OCT), have enhanced the ability to diagnose and monitor eye diseases accurately.
In the Americas, the market benefits from a well-established healthcare system, increasing public awareness, and the presence of major pharmaceutical and medical device companies. The growing aging population and the high incidence of conditions like AMD and glaucoma further support market growth.
The Asia Pacific region is expected to witness the highest growth rate, driven by the rapidly aging population, increasing healthcare expenditures, and rising awareness of age-related eye diseases. Countries like China, Japan, and South Korea are key markets, with expanding healthcare infrastructure and a focus on improving access to eye care services.
In Europe, the market for Age-related Vision Dysfunction treatments is driven by strong healthcare systems, high patient awareness, and the availability of advanced therapeutic options. Countries like Germany, France, and the UK are significant contributors, with a focus on research and development in ophthalmology
This product will be delivered within 2 business days.
The report explores a multi-faceted opportunity landscape in terms of market segmentation by Drug (Eylea, Lucentis, Combigan, Beovu and Other Drugs), By Dysfunction Type (Glaucoma, Cataract, Presbyopia and AMD) and By Distribution Channel (Online Pharmacies and Retail Pharmacies)
Market Overview
The Age-related Vision Dysfunction market has seen considerable growth due to the increasing prevalence of age-related eye diseases, the growing aging population, and advancements in diagnostic and therapeutic technologies. Age-related vision dysfunction encompasses various conditions such as age-related macular degeneration (AMD), cataracts, glaucoma, and diabetic retinopathy. The market is driven by the need for effective diagnosis, management, and treatment of these conditions to improve the quality of life for elderly patients.One of the primary drivers of the Age-related Vision Dysfunction market is the rising prevalence of age-related eye diseases. As the global population ages, the incidence of conditions like AMD, cataracts, and glaucoma increases, leading to greater demand for medical interventions. The growing awareness of these conditions and the importance of regular eye exams have also contributed to market growth, as early detection and treatment can prevent or slow the progression of vision loss.
The increasing focus on innovative treatment options and the development of advanced diagnostic technologies have significantly influenced the market. New therapies, such as anti-VEGF injections for AMD and minimally invasive glaucoma surgeries, offer improved outcomes and fewer side effects. Additionally, advancements in imaging technologies, like optical coherence tomography (OCT), have enhanced the ability to diagnose and monitor eye diseases accurately.
Segment Insights
By dysfunction type, the age-related macular degeneration (AMD) segment holds the largest market share, accounting for approximately 45% of the global Age-related Vision Dysfunction market in 2023. The high prevalence of AMD among the elderly population and the availability of effective treatments drive this segment.Geographical Insights
Americas represent the largest market for Age-related Vision Dysfunction treatments, driven by a high prevalence of age-related eye diseases, advanced healthcare infrastructure, and strong investment in ophthalmology research. The United States is a key market, with a significant focus on developing new treatments and improving patient care.In the Americas, the market benefits from a well-established healthcare system, increasing public awareness, and the presence of major pharmaceutical and medical device companies. The growing aging population and the high incidence of conditions like AMD and glaucoma further support market growth.
The Asia Pacific region is expected to witness the highest growth rate, driven by the rapidly aging population, increasing healthcare expenditures, and rising awareness of age-related eye diseases. Countries like China, Japan, and South Korea are key markets, with expanding healthcare infrastructure and a focus on improving access to eye care services.
In Europe, the market for Age-related Vision Dysfunction treatments is driven by strong healthcare systems, high patient awareness, and the availability of advanced therapeutic options. Countries like Germany, France, and the UK are significant contributors, with a focus on research and development in ophthalmology
Market Segmentation
By Drug:
- Eylea
- Lucentis
- Combigan
- Beovu
- Other Drugs
By Dysfunction Type:
- Glaucoma
- Cataract
- Presbyopia
- AMD
By Distribution Channel:
- Online Pharmacies
- Retail Pharmacies
By Geography:
- Americas (The United States, Canada, Brazil, Mexico, Rest of Americas)
- Europe (United Kingdom, Germany, France, Italy, Spain, Turkey, Russia, Rest of Europe)
- Asia Pacific (China, Japan, South Korea, India, Singapore, Indonesia, Rest of Asia Pacific)
- Middle East and Africa (GCC, Israel, South Africa, Rest of Middle East and Africa)
Key Companies
The report assesses the competitive developments, strategies, mergers and acquisitions and new product development and market share portfolio of top 15 companies. Key companies in the Global Age-related Vision Dysfunction Market include:- Bausch + Lomb
- D Western Therapeutics Institute
- Novartis
- IVERIC Bio
- Santen Pharmaceutical
- AbbVie
- Aerie Pharmaceuticals
- Eyenovia
- Sun Pharma Advanced Research Company Limited
- Orasis Pharmaceuticals
- Other Leading Companies
Reasons to buy this report:
- In-Depth Comparative Assessment of Top 20 Markets in the Age-related Vision Dysfunction Market: Comparative assessment of 20 leading countries highlighting the total addressable market, opportunities, lucrative segments and competitive positioning of leading companies.
- Comprehensive Historical, Present, and Future Analytics of the Age-related Vision Dysfunction Market: A deep dive in the historical (2020-2023), current (2024) and forecast (2025-2030) market analytics of Age-related Vision Dysfunction Market.
- Detailed Analysis of Age-related Vision Dysfunction Market By Drug, Dysfunction Type, and Distribution Channel Across 20 Countries
- Beyond the Purchase: 90 Days of Support
- Direct Access to Analysts: Have questions after reading the report? Our expert analysts are just a call or email away.
- Customized Assistance: Whether you're integrating insights into your strategy or have questions about market dynamics, our team provides tailored support to meet your specific business needs.
- Data Customization Requests: During the support period, you have the flexibility to request additional data cuts or deeper dives into specific areas of interest.
- Gain insights specific to new entrants or new market areas to tap: The study provides detailed market entry strategies, including analysis of barriers to entry, pricing strategies, opportunities, trends, drivers, and challenges and product positioning using the Opportunity Portfolio Matrix (OPM)
- Strategic Company Movements: Tracking Competitive Developments and Key Players in the Market: The report covers competitive strategies, mergers & acquisitions, new developments, future plans and market share analysis of ~15 top companies.
This product will be delivered within 2 business days.
Table of Contents
1. Market Background
1.1 Scope and Product Outlook
1.2 Executive Summary
1.3 Research Methodology
1.2 Executive Summary
1.3 Research Methodology
3. Global Age-related Vision Dysfunction Market: Historic and Forecast
3.1 Impact Analysis of Macro Economic Factors on Global Age-related Vision Dysfunction Market
3.2 Age-related Vision Dysfunction Market Type Matrix
3.3 Global Age-related Vision Dysfunction Market: Dashboard
3.4 Global Age-related Vision Dysfunction Market: Market Size and CAGR, By Value, 2020-2030 (USD Million & CAGR)
3.5 Global Age-related Vision Dysfunction Market: Market Value Assessment
3.6 Assessment Degree of Impact of COVID-19 on Global Age-related Vision Dysfunction Market
3.7 Global Age-related Vision Dysfunction Market Segmentation: By Drug
3.7.1 Global Age-related Vision Dysfunction Market, By Drug Overview
3.7.2 Global Age-related Vision Dysfunction Market Attractiveness Index, By Drug (2025-2030)
3.7.3 Global Age-related Vision Dysfunction Market Size, By Eylea, By Value, 2020H-2030F (USD Million & CAGR)
3.7.4 Global Age-related Vision Dysfunction Market Size, By Lucentis, By Value, 2020H-2030F (USD Million & CAGR)
3.7.5 Global Age-related Vision Dysfunction Market Size, By Combigan, By Value, 2020H-2030F (USD Million & CAGR)
3.7.6 Global Age-related Vision Dysfunction Market Size, By Beovu, By Value, 2020H-2030F (USD Million & CAGR)
3.7.7 Global Age-related Vision Dysfunction Market Size, By Other Drugs, By Value, 2020H-2030F (USD Million & CAGR)
3.8 Global Age-related Vision Dysfunction Market Segmentation: By Dysfunction Type
3.8.1 Global Age-related Vision Dysfunction Market, By Dysfunction Type Overview
3.8.2 Global Age-related Vision Dysfunction Market Attractiveness Index, By Dysfunction Type (2025-2030)
3.8.3 Global Age-related Vision Dysfunction Market Size, By Glaucoma, By Value, 2020H-2030F (USD Million & CAGR)
3.8.4 Global Age-related Vision Dysfunction Market Size, By Cataract, By Value, 2020H-2030F (USD Million & CAGR)
3.8.5 Global Age-related Vision Dysfunction Market Size, By Presbyopia, By Value, 2020H-2030F (USD Million & CAGR)
3.8.6 Global Age-related Vision Dysfunction Market Size, By AMD, By Value, 2020H-2030F (USD Million & CAGR)
3.9 Global Age-related Vision Dysfunction Market Segmentation: By Distribution Channel
3.9.1 Global Age-related Vision Dysfunction Market, By Distribution Channel Overview
3.9.2 Global Age-related Vision Dysfunction Market Attractiveness Index, By Distribution Channel (2025-2030)
3.9.3 Global Age-related Vision Dysfunction Market Size, By Online Pharmacies, By Value, 2020H-2030F (USD Million & CAGR)
3.9.4 Global Age-related Vision Dysfunction Market Size, By Retail Pharmacies , By Value, 2020H-2030F (USD Million & CAGR)
3.2 Age-related Vision Dysfunction Market Type Matrix
3.3 Global Age-related Vision Dysfunction Market: Dashboard
3.4 Global Age-related Vision Dysfunction Market: Market Size and CAGR, By Value, 2020-2030 (USD Million & CAGR)
3.5 Global Age-related Vision Dysfunction Market: Market Value Assessment
3.6 Assessment Degree of Impact of COVID-19 on Global Age-related Vision Dysfunction Market
3.7 Global Age-related Vision Dysfunction Market Segmentation: By Drug
3.7.1 Global Age-related Vision Dysfunction Market, By Drug Overview
3.7.2 Global Age-related Vision Dysfunction Market Attractiveness Index, By Drug (2025-2030)
3.7.3 Global Age-related Vision Dysfunction Market Size, By Eylea, By Value, 2020H-2030F (USD Million & CAGR)
3.7.4 Global Age-related Vision Dysfunction Market Size, By Lucentis, By Value, 2020H-2030F (USD Million & CAGR)
3.7.5 Global Age-related Vision Dysfunction Market Size, By Combigan, By Value, 2020H-2030F (USD Million & CAGR)
3.7.6 Global Age-related Vision Dysfunction Market Size, By Beovu, By Value, 2020H-2030F (USD Million & CAGR)
3.7.7 Global Age-related Vision Dysfunction Market Size, By Other Drugs, By Value, 2020H-2030F (USD Million & CAGR)
3.8 Global Age-related Vision Dysfunction Market Segmentation: By Dysfunction Type
3.8.1 Global Age-related Vision Dysfunction Market, By Dysfunction Type Overview
3.8.2 Global Age-related Vision Dysfunction Market Attractiveness Index, By Dysfunction Type (2025-2030)
3.8.3 Global Age-related Vision Dysfunction Market Size, By Glaucoma, By Value, 2020H-2030F (USD Million & CAGR)
3.8.4 Global Age-related Vision Dysfunction Market Size, By Cataract, By Value, 2020H-2030F (USD Million & CAGR)
3.8.5 Global Age-related Vision Dysfunction Market Size, By Presbyopia, By Value, 2020H-2030F (USD Million & CAGR)
3.8.6 Global Age-related Vision Dysfunction Market Size, By AMD, By Value, 2020H-2030F (USD Million & CAGR)
3.9 Global Age-related Vision Dysfunction Market Segmentation: By Distribution Channel
3.9.1 Global Age-related Vision Dysfunction Market, By Distribution Channel Overview
3.9.2 Global Age-related Vision Dysfunction Market Attractiveness Index, By Distribution Channel (2025-2030)
3.9.3 Global Age-related Vision Dysfunction Market Size, By Online Pharmacies, By Value, 2020H-2030F (USD Million & CAGR)
3.9.4 Global Age-related Vision Dysfunction Market Size, By Retail Pharmacies , By Value, 2020H-2030F (USD Million & CAGR)
4. Age-related Vision Dysfunction Market, Region Analysis
4.1 Regional Coverage of the Study
4.2 Regional Snapshot
4.2 Regional Snapshot
5. Americas Age-related Vision Dysfunction Market: Historic and Forecast
5.1 Americas Age-related Vision Dysfunction Market: Snapshot
5.2 Americas Age-related Vision Dysfunction Market: Market Size and CAGR, By Value, 2020-2030 (USD Million & CAGR)
5.3 Americas Age-related Vision Dysfunction Market: Key Factors
5.4 Americas Age-related Vision Dysfunction Market: Segment Analysis
5.5 Americas Age-related Vision Dysfunction Market Segmentation: By Drug
5.5.1 Americas Age-related Vision Dysfunction Market, By Drug Overview
5.5.2 Americas Age-related Vision Dysfunction Market Size, By Eylea, By Value, 2020H-2030F (USD Million & CAGR)
5.5.3 Americas Age-related Vision Dysfunction Market Size, By Lucentis, By Value, 2020H-2030F (USD Million & CAGR)
5.5.4 Americas Age-related Vision Dysfunction Market Size, By Combigan, By Value, 2020H-2030F (USD Million & CAGR)
5.5.5 Americas Age-related Vision Dysfunction Market Size, By Beovu, By Value, 2020H-2030F (USD Million & CAGR)
5.5.6 Americas Age-related Vision Dysfunction Market Size, By Other Drugs, By Value, 2020H-2030F (USD Million & CAGR)
5.6 Americas Age-related Vision Dysfunction Market Segmentation: By Dysfunction Type
5.6.1 Americas Age-related Vision Dysfunction Market, By Dysfunction Type Overview
5.6.2 Americas Age-related Vision Dysfunction Market Size, By Glaucoma, By Value, 2020H-2030F (USD Million & CAGR)
5.6.3 Americas Age-related Vision Dysfunction Market Size, By Cataract, By Value, 2020H-2030F (USD Million & CAGR)
5.6.4 Americas Age-related Vision Dysfunction Market Size, By Presbyopia, By Value, 2020H-2030F (USD Million & CAGR)
5.6.5 Americas Age-related Vision Dysfunction Market Size, By AMD, By Value, 2020H-2030F (USD Million & CAGR)
5.7 Americas Age-related Vision Dysfunction Market Segmentation: By Distribution Channel
5.7.1 Americas Age-related Vision Dysfunction Market, By Distribution Channel Overview
5.7.2 Americas Age-related Vision Dysfunction Market Size, By Online Pharmacies, By Value, 2020H-2030F (USD Million & CAGR)
5.7.3 Americas Age-related Vision Dysfunction Market Size, By Retail Pharmacies , By Value, 2020H-2030F (USD Million & CAGR)
5.8 Americas Age-related Vision Dysfunction Market Segmentation: By Country
5.8.1 Americas Age-related Vision Dysfunction Market, by Country Overview
5.8.2 United States Age-related Vision Dysfunction Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
5.8.2.1 United States Age-related Vision Dysfunction Market, By Drug
5.8.2.2 United States Age-related Vision Dysfunction Market, By Dysfunction Type
5.8.2.3 United States Age-related Vision Dysfunction Market, By Distribution Channel
5.8.3 Canada Age-related Vision Dysfunction Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
5.8.3.1 Canada Age-related Vision Dysfunction Market, By Drug
5.8.3.2 Canada Age-related Vision Dysfunction Market, By Dysfunction Type
5.8.3.3 Canada Age-related Vision Dysfunction Market, By Distribution Channel
5.8.4 Brazil Age-related Vision Dysfunction Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
5.8.4.1 Brazil Age-related Vision Dysfunction Market, By Drug
5.8.4.2 Brazil Age-related Vision Dysfunction Market, By Dysfunction Type
5.8.4.3 Brazil Age-related Vision Dysfunction Market, By Distribution Channel
5.8.5 Mexico Age-related Vision Dysfunction Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
5.8.5.1 Mexico Age-related Vision Dysfunction Market, By Drug
5.8.5.2 Mexico Age-related Vision Dysfunction Market, By Dysfunction Type
5.8.5.3 Mexico Age-related Vision Dysfunction Market, By Distribution Channel
5.8.6 Rest of Americas Age-related Vision Dysfunction Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
5.8.6.1 Rest of Americas Age-related Vision Dysfunction Market, By Drug
5.8.6.2 Rest of Americas Age-related Vision Dysfunction Market, By Dysfunction Type
5.8.6.3 Rest of Americas Age-related Vision Dysfunction Market, By Distribution Channel
5.2 Americas Age-related Vision Dysfunction Market: Market Size and CAGR, By Value, 2020-2030 (USD Million & CAGR)
5.3 Americas Age-related Vision Dysfunction Market: Key Factors
5.4 Americas Age-related Vision Dysfunction Market: Segment Analysis
5.5 Americas Age-related Vision Dysfunction Market Segmentation: By Drug
5.5.1 Americas Age-related Vision Dysfunction Market, By Drug Overview
5.5.2 Americas Age-related Vision Dysfunction Market Size, By Eylea, By Value, 2020H-2030F (USD Million & CAGR)
5.5.3 Americas Age-related Vision Dysfunction Market Size, By Lucentis, By Value, 2020H-2030F (USD Million & CAGR)
5.5.4 Americas Age-related Vision Dysfunction Market Size, By Combigan, By Value, 2020H-2030F (USD Million & CAGR)
5.5.5 Americas Age-related Vision Dysfunction Market Size, By Beovu, By Value, 2020H-2030F (USD Million & CAGR)
5.5.6 Americas Age-related Vision Dysfunction Market Size, By Other Drugs, By Value, 2020H-2030F (USD Million & CAGR)
5.6 Americas Age-related Vision Dysfunction Market Segmentation: By Dysfunction Type
5.6.1 Americas Age-related Vision Dysfunction Market, By Dysfunction Type Overview
5.6.2 Americas Age-related Vision Dysfunction Market Size, By Glaucoma, By Value, 2020H-2030F (USD Million & CAGR)
5.6.3 Americas Age-related Vision Dysfunction Market Size, By Cataract, By Value, 2020H-2030F (USD Million & CAGR)
5.6.4 Americas Age-related Vision Dysfunction Market Size, By Presbyopia, By Value, 2020H-2030F (USD Million & CAGR)
5.6.5 Americas Age-related Vision Dysfunction Market Size, By AMD, By Value, 2020H-2030F (USD Million & CAGR)
5.7 Americas Age-related Vision Dysfunction Market Segmentation: By Distribution Channel
5.7.1 Americas Age-related Vision Dysfunction Market, By Distribution Channel Overview
5.7.2 Americas Age-related Vision Dysfunction Market Size, By Online Pharmacies, By Value, 2020H-2030F (USD Million & CAGR)
5.7.3 Americas Age-related Vision Dysfunction Market Size, By Retail Pharmacies , By Value, 2020H-2030F (USD Million & CAGR)
5.8 Americas Age-related Vision Dysfunction Market Segmentation: By Country
5.8.1 Americas Age-related Vision Dysfunction Market, by Country Overview
5.8.2 United States Age-related Vision Dysfunction Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
5.8.2.1 United States Age-related Vision Dysfunction Market, By Drug
5.8.2.2 United States Age-related Vision Dysfunction Market, By Dysfunction Type
5.8.2.3 United States Age-related Vision Dysfunction Market, By Distribution Channel
5.8.3 Canada Age-related Vision Dysfunction Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
5.8.3.1 Canada Age-related Vision Dysfunction Market, By Drug
5.8.3.2 Canada Age-related Vision Dysfunction Market, By Dysfunction Type
5.8.3.3 Canada Age-related Vision Dysfunction Market, By Distribution Channel
5.8.4 Brazil Age-related Vision Dysfunction Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
5.8.4.1 Brazil Age-related Vision Dysfunction Market, By Drug
5.8.4.2 Brazil Age-related Vision Dysfunction Market, By Dysfunction Type
5.8.4.3 Brazil Age-related Vision Dysfunction Market, By Distribution Channel
5.8.5 Mexico Age-related Vision Dysfunction Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
5.8.5.1 Mexico Age-related Vision Dysfunction Market, By Drug
5.8.5.2 Mexico Age-related Vision Dysfunction Market, By Dysfunction Type
5.8.5.3 Mexico Age-related Vision Dysfunction Market, By Distribution Channel
5.8.6 Rest of Americas Age-related Vision Dysfunction Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
5.8.6.1 Rest of Americas Age-related Vision Dysfunction Market, By Drug
5.8.6.2 Rest of Americas Age-related Vision Dysfunction Market, By Dysfunction Type
5.8.6.3 Rest of Americas Age-related Vision Dysfunction Market, By Distribution Channel
6. Europe Age-related Vision Dysfunction Market: Historic and Forecast
6.1 Europe Age-related Vision Dysfunction Market: Snapshot
6.2 Europe Age-related Vision Dysfunction Market: Market Size and CAGR, BY Value, 2020-2030 (USD Million & CAGR)
6.3 Europe Age-related Vision Dysfunction Market: Key Factors
6.4 Europe Age-related Vision Dysfunction Market: Segment Analysis
6.5 Europe Age-related Vision Dysfunction Market Segmentation: By Drug
6.5.1 Europe Age-related Vision Dysfunction Market, By Drug Overview
6.5.2 Europe Age-related Vision Dysfunction Market Size, By Eylea, By Value, 2020H-2030F (USD Million & CAGR)
6.5.3 Europe Age-related Vision Dysfunction Market Size, By Lucentis, By Value, 2020H-2030F (USD Million & CAGR)
6.5.4 Europe Age-related Vision Dysfunction Market Size, By Combigan, By Value, 2020H-2030F (USD Million & CAGR)
6.5.5 Europe Age-related Vision Dysfunction Market Size, By Beovu, By Value, 2020H-2030F (USD Million & CAGR)
6.5.6 Europe Age-related Vision Dysfunction Market Size, By Other Drugs, By Value, 2020H-2030F (USD Million & CAGR)
6.6 Europe Age-related Vision Dysfunction Market Segmentation: By Dysfunction Type
6.6.1 Europe Age-related Vision Dysfunction Market, By Dysfunction Type Overview
6.6.2 Europe Age-related Vision Dysfunction Market Size, By Glaucoma, By Value, 2020H-2030F (USD Million & CAGR)
6.6.3 Europe Age-related Vision Dysfunction Market Size, By Cataract, By Value, 2020H-2030F (USD Million & CAGR)
6.6.4 Europe Age-related Vision Dysfunction Market Size, By Presbyopia, By Value, 2020H-2030F (USD Million & CAGR)
6.6.5 Europe Age-related Vision Dysfunction Market Size, By AMD, By Value, 2020H-2030F (USD Million & CAGR)
6.7 Europe Age-related Vision Dysfunction Market Segmentation: By Distribution Channel
6.7.1 Europe Age-related Vision Dysfunction Market, By Distribution Channel Overview
6.7.2 Europe Age-related Vision Dysfunction Market Size, By Online Pharmacies, By Value, 2020H-2030F (USD Million & CAGR)
6.7.3 Europe Age-related Vision Dysfunction Market Size, By Retail Pharmacies , By Value, 2020H-2030F (USD Million & CAGR)
6.8 Europe Age-related Vision Dysfunction Market Segmentation: By Country
6.8.1 Europe Age-related Vision Dysfunction Market, by Country Overview
6.8.2 Russia Age-related Vision Dysfunction Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.8.2.1 Russia Age-related Vision Dysfunction Market, By Drug
6.8.2.2 Russia Age-related Vision Dysfunction Market, By Dysfunction Type
6.8.2.3 Russia Age-related Vision Dysfunction Market, By Distribution Channel
6.8.3 France Age-related Vision Dysfunction Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.8.3.1 France Age-related Vision Dysfunction Market, By Drug
6.8.3.2 France Age-related Vision Dysfunction Market, By Dysfunction Type
6.8.3.3 France Age-related Vision Dysfunction Market, By Distribution Channel
6.8.4 United Kingdom Age-related Vision Dysfunction Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.8.4.1 United Kingdom Age-related Vision Dysfunction Market, By Drug
6.8.4.2 United Kingdom Age-related Vision Dysfunction Market, By Dysfunction Type
6.8.4.3 United Kingdom Age-related Vision Dysfunction Market, By Distribution Channel
6.8.5 Germany Age-related Vision Dysfunction Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.8.5.1 Germany Age-related Vision Dysfunction Market, By Drug
6.8.5.2 Germany Age-related Vision Dysfunction Market, By Dysfunction Type
6.8.5.3 Germany Age-related Vision Dysfunction Market, By Distribution Channel
6.8.6 Italy Age-related Vision Dysfunction Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.8.6.1 Italy Age-related Vision Dysfunction Market, By Drug
6.8.6.2 Italy Age-related Vision Dysfunction Market, By Dysfunction Type
6.8.6.3 Italy Age-related Vision Dysfunction Market, By Distribution Channel
6.8.7 Spain Age-related Vision Dysfunction Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.8.7.1 Spain Age-related Vision Dysfunction Market, By Drug
6.8.7.2 Spain Age-related Vision Dysfunction Market, By Dysfunction Type
6.8.7.3 Spain Age-related Vision Dysfunction Market, By Distribution Channel
6.8.8 Turkey Age-related Vision Dysfunction Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.8.8.1 Turkey Age-related Vision Dysfunction Market, By Drug
6.8.8.2 Turkey Age-related Vision Dysfunction Market, By Dysfunction Type
6.8.8.3 Turkey Age-related Vision Dysfunction Market, By Distribution Channel
6.8.9 Rest of Europe Age-related Vision Dysfunction Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.8.9.1 Rest of Europe Age-related Vision Dysfunction Market, By Drug
6.8.9.2 Rest of Europe Age-related Vision Dysfunction Market, By Dysfunction Type
6.8.9.3 Rest of Europe Age-related Vision Dysfunction Market, By Distribution Channel
6.2 Europe Age-related Vision Dysfunction Market: Market Size and CAGR, BY Value, 2020-2030 (USD Million & CAGR)
6.3 Europe Age-related Vision Dysfunction Market: Key Factors
6.4 Europe Age-related Vision Dysfunction Market: Segment Analysis
6.5 Europe Age-related Vision Dysfunction Market Segmentation: By Drug
6.5.1 Europe Age-related Vision Dysfunction Market, By Drug Overview
6.5.2 Europe Age-related Vision Dysfunction Market Size, By Eylea, By Value, 2020H-2030F (USD Million & CAGR)
6.5.3 Europe Age-related Vision Dysfunction Market Size, By Lucentis, By Value, 2020H-2030F (USD Million & CAGR)
6.5.4 Europe Age-related Vision Dysfunction Market Size, By Combigan, By Value, 2020H-2030F (USD Million & CAGR)
6.5.5 Europe Age-related Vision Dysfunction Market Size, By Beovu, By Value, 2020H-2030F (USD Million & CAGR)
6.5.6 Europe Age-related Vision Dysfunction Market Size, By Other Drugs, By Value, 2020H-2030F (USD Million & CAGR)
6.6 Europe Age-related Vision Dysfunction Market Segmentation: By Dysfunction Type
6.6.1 Europe Age-related Vision Dysfunction Market, By Dysfunction Type Overview
6.6.2 Europe Age-related Vision Dysfunction Market Size, By Glaucoma, By Value, 2020H-2030F (USD Million & CAGR)
6.6.3 Europe Age-related Vision Dysfunction Market Size, By Cataract, By Value, 2020H-2030F (USD Million & CAGR)
6.6.4 Europe Age-related Vision Dysfunction Market Size, By Presbyopia, By Value, 2020H-2030F (USD Million & CAGR)
6.6.5 Europe Age-related Vision Dysfunction Market Size, By AMD, By Value, 2020H-2030F (USD Million & CAGR)
6.7 Europe Age-related Vision Dysfunction Market Segmentation: By Distribution Channel
6.7.1 Europe Age-related Vision Dysfunction Market, By Distribution Channel Overview
6.7.2 Europe Age-related Vision Dysfunction Market Size, By Online Pharmacies, By Value, 2020H-2030F (USD Million & CAGR)
6.7.3 Europe Age-related Vision Dysfunction Market Size, By Retail Pharmacies , By Value, 2020H-2030F (USD Million & CAGR)
6.8 Europe Age-related Vision Dysfunction Market Segmentation: By Country
6.8.1 Europe Age-related Vision Dysfunction Market, by Country Overview
6.8.2 Russia Age-related Vision Dysfunction Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.8.2.1 Russia Age-related Vision Dysfunction Market, By Drug
6.8.2.2 Russia Age-related Vision Dysfunction Market, By Dysfunction Type
6.8.2.3 Russia Age-related Vision Dysfunction Market, By Distribution Channel
6.8.3 France Age-related Vision Dysfunction Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.8.3.1 France Age-related Vision Dysfunction Market, By Drug
6.8.3.2 France Age-related Vision Dysfunction Market, By Dysfunction Type
6.8.3.3 France Age-related Vision Dysfunction Market, By Distribution Channel
6.8.4 United Kingdom Age-related Vision Dysfunction Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.8.4.1 United Kingdom Age-related Vision Dysfunction Market, By Drug
6.8.4.2 United Kingdom Age-related Vision Dysfunction Market, By Dysfunction Type
6.8.4.3 United Kingdom Age-related Vision Dysfunction Market, By Distribution Channel
6.8.5 Germany Age-related Vision Dysfunction Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.8.5.1 Germany Age-related Vision Dysfunction Market, By Drug
6.8.5.2 Germany Age-related Vision Dysfunction Market, By Dysfunction Type
6.8.5.3 Germany Age-related Vision Dysfunction Market, By Distribution Channel
6.8.6 Italy Age-related Vision Dysfunction Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.8.6.1 Italy Age-related Vision Dysfunction Market, By Drug
6.8.6.2 Italy Age-related Vision Dysfunction Market, By Dysfunction Type
6.8.6.3 Italy Age-related Vision Dysfunction Market, By Distribution Channel
6.8.7 Spain Age-related Vision Dysfunction Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.8.7.1 Spain Age-related Vision Dysfunction Market, By Drug
6.8.7.2 Spain Age-related Vision Dysfunction Market, By Dysfunction Type
6.8.7.3 Spain Age-related Vision Dysfunction Market, By Distribution Channel
6.8.8 Turkey Age-related Vision Dysfunction Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.8.8.1 Turkey Age-related Vision Dysfunction Market, By Drug
6.8.8.2 Turkey Age-related Vision Dysfunction Market, By Dysfunction Type
6.8.8.3 Turkey Age-related Vision Dysfunction Market, By Distribution Channel
6.8.9 Rest of Europe Age-related Vision Dysfunction Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.8.9.1 Rest of Europe Age-related Vision Dysfunction Market, By Drug
6.8.9.2 Rest of Europe Age-related Vision Dysfunction Market, By Dysfunction Type
6.8.9.3 Rest of Europe Age-related Vision Dysfunction Market, By Distribution Channel
7. Asia Pacific Age-related Vision Dysfunction Market: Historic and Forecast
7.1 Asia Pacific Age-related Vision Dysfunction Market: Snapshot
7.2 Asia Pacific Age-related Vision Dysfunction Market: Market Size and CAGR, By Value, 2020-2030 (USD Million & CAGR)
7.3 Asia Pacific Age-related Vision Dysfunction Market: Key Factors
7.4 Asia Pacific Age-related Vision Dysfunction Market: Segment Analysis
7.5 Asia Pacific Age-related Vision Dysfunction Market Segmentation: By Drug
7.5.1 Asia Pacific Age-related Vision Dysfunction Market, By Drug Overview
7.5.2 Asia Pacific Age-related Vision Dysfunction Market Size, By Eylea, By Value, 2020H-2030F (USD Million & CAGR)
7.5.3 Asia Pacific Age-related Vision Dysfunction Market Size, By Lucentis, By Value, 2020H-2030F (USD Million & CAGR)
7.5.4 Asia Pacific Age-related Vision Dysfunction Market Size, By Combigan, By Value, 2020H-2030F (USD Million & CAGR)
7.5.5 Asia Pacific Age-related Vision Dysfunction Market Size, By Beovu, By Value, 2020H-2030F (USD Million & CAGR)
7.5.6 Asia Pacific Age-related Vision Dysfunction Market Size, By Other Drugs, By Value, 2020H-2030F (USD Million & CAGR)
7.6 Asia Pacific Age-related Vision Dysfunction Market Segmentation: By Dysfunction Type
7.6.1 Asia Pacific Age-related Vision Dysfunction Market, By Dysfunction Type Overview
7.6.2 Asia Pacific Age-related Vision Dysfunction Market Size, By Glaucoma, By Value, 2020H-2030F (USD Million & CAGR)
7.6.3 Asia Pacific Age-related Vision Dysfunction Market Size, By Cataract, By Value, 2020H-2030F (USD Million & CAGR)
7.6.4 Asia Pacific Age-related Vision Dysfunction Market Size, By Presbyopia, By Value, 2020H-2030F (USD Million & CAGR)
7.6.5 Asia Pacific Age-related Vision Dysfunction Market Size, By AMD, By Value, 2020H-2030F (USD Million & CAGR)
7.7 Asia Pacific Age-related Vision Dysfunction Market Segmentation: By Distribution Channel
7.7.1 Asia Pacific Age-related Vision Dysfunction Market, By Distribution Channel Overview
7.7.2 Asia Pacific Age-related Vision Dysfunction Market Size, By Online Pharmacies, By Value, 2020H-2030F (USD Million & CAGR)
7.7.3 Asia Pacific Age-related Vision Dysfunction Market Size, By Retail Pharmacies , By Value, 2020H-2030F (USD Million & CAGR)
7.8 Asia Pacific Age-related Vision Dysfunction Market Segmentation: By Country
7.8.1 Asia Pacific Age-related Vision Dysfunction Market, by Country Overview
7.8.2 China Age-related Vision Dysfunction Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.8.2.1 China Age-related Vision Dysfunction Market, By Drug
7.8.2.2 China Age-related Vision Dysfunction Market, By Dysfunction Type
7.8.2.3 China Age-related Vision Dysfunction Market, By Distribution Channel
7.8.3 India Age-related Vision Dysfunction Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.8.3.1 India Age-related Vision Dysfunction Market, By Drug
7.8.3.2 India Age-related Vision Dysfunction Market, By Dysfunction Type
7.8.3.3 India Age-related Vision Dysfunction Market, By Distribution Channel
7.8.4 South Korea Age-related Vision Dysfunction Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.8.4.1 South Korea Age-related Vision Dysfunction Market, By Drug
7.8.4.2 South Korea Age-related Vision Dysfunction Market, By Dysfunction Type
7.8.4.3 South Korea Age-related Vision Dysfunction Market, By Distribution Channel
7.8.5 Japan Korea Age-related Vision Dysfunction Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.8.5.1 Japan Age-related Vision Dysfunction Market, By Drug
7.8.5.2 Japan Age-related Vision Dysfunction Market, By Dysfunction Type
7.8.5.3 Japan Age-related Vision Dysfunction Market, By Distribution Channel
7.8.6 Singapore Age-related Vision Dysfunction Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.8.6.1 Singapore Age-related Vision Dysfunction Market, By Drug
7.8.6.2 Singapore Age-related Vision Dysfunction Market, By Dysfunction Type
7.8.6.3 Singapore Age-related Vision Dysfunction Market, By Distribution Channel
7.8.7 Indonesia Age-related Vision Dysfunction Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.8.7.1 Indonesia Age-related Vision Dysfunction Market, By Drug
7.8.7.2 Indonesia Age-related Vision Dysfunction Market, By Dysfunction Type
7.8.7.3 Indonesia Age-related Vision Dysfunction Market, By Distribution Channel
7.8.8 Rest of Asia Pacific Age-related Vision Dysfunction Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.8.8.1 Rest of Asia Pacific Age-related Vision Dysfunction Market, By Drug
7.8.8.2 Rest of Asia Pacific Age-related Vision Dysfunction Market, By Dysfunction Type
7.8.8.3 Rest of Asia Pacific Age-related Vision Dysfunction Market, By Distribution Channel
7.2 Asia Pacific Age-related Vision Dysfunction Market: Market Size and CAGR, By Value, 2020-2030 (USD Million & CAGR)
7.3 Asia Pacific Age-related Vision Dysfunction Market: Key Factors
7.4 Asia Pacific Age-related Vision Dysfunction Market: Segment Analysis
7.5 Asia Pacific Age-related Vision Dysfunction Market Segmentation: By Drug
7.5.1 Asia Pacific Age-related Vision Dysfunction Market, By Drug Overview
7.5.2 Asia Pacific Age-related Vision Dysfunction Market Size, By Eylea, By Value, 2020H-2030F (USD Million & CAGR)
7.5.3 Asia Pacific Age-related Vision Dysfunction Market Size, By Lucentis, By Value, 2020H-2030F (USD Million & CAGR)
7.5.4 Asia Pacific Age-related Vision Dysfunction Market Size, By Combigan, By Value, 2020H-2030F (USD Million & CAGR)
7.5.5 Asia Pacific Age-related Vision Dysfunction Market Size, By Beovu, By Value, 2020H-2030F (USD Million & CAGR)
7.5.6 Asia Pacific Age-related Vision Dysfunction Market Size, By Other Drugs, By Value, 2020H-2030F (USD Million & CAGR)
7.6 Asia Pacific Age-related Vision Dysfunction Market Segmentation: By Dysfunction Type
7.6.1 Asia Pacific Age-related Vision Dysfunction Market, By Dysfunction Type Overview
7.6.2 Asia Pacific Age-related Vision Dysfunction Market Size, By Glaucoma, By Value, 2020H-2030F (USD Million & CAGR)
7.6.3 Asia Pacific Age-related Vision Dysfunction Market Size, By Cataract, By Value, 2020H-2030F (USD Million & CAGR)
7.6.4 Asia Pacific Age-related Vision Dysfunction Market Size, By Presbyopia, By Value, 2020H-2030F (USD Million & CAGR)
7.6.5 Asia Pacific Age-related Vision Dysfunction Market Size, By AMD, By Value, 2020H-2030F (USD Million & CAGR)
7.7 Asia Pacific Age-related Vision Dysfunction Market Segmentation: By Distribution Channel
7.7.1 Asia Pacific Age-related Vision Dysfunction Market, By Distribution Channel Overview
7.7.2 Asia Pacific Age-related Vision Dysfunction Market Size, By Online Pharmacies, By Value, 2020H-2030F (USD Million & CAGR)
7.7.3 Asia Pacific Age-related Vision Dysfunction Market Size, By Retail Pharmacies , By Value, 2020H-2030F (USD Million & CAGR)
7.8 Asia Pacific Age-related Vision Dysfunction Market Segmentation: By Country
7.8.1 Asia Pacific Age-related Vision Dysfunction Market, by Country Overview
7.8.2 China Age-related Vision Dysfunction Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.8.2.1 China Age-related Vision Dysfunction Market, By Drug
7.8.2.2 China Age-related Vision Dysfunction Market, By Dysfunction Type
7.8.2.3 China Age-related Vision Dysfunction Market, By Distribution Channel
7.8.3 India Age-related Vision Dysfunction Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.8.3.1 India Age-related Vision Dysfunction Market, By Drug
7.8.3.2 India Age-related Vision Dysfunction Market, By Dysfunction Type
7.8.3.3 India Age-related Vision Dysfunction Market, By Distribution Channel
7.8.4 South Korea Age-related Vision Dysfunction Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.8.4.1 South Korea Age-related Vision Dysfunction Market, By Drug
7.8.4.2 South Korea Age-related Vision Dysfunction Market, By Dysfunction Type
7.8.4.3 South Korea Age-related Vision Dysfunction Market, By Distribution Channel
7.8.5 Japan Korea Age-related Vision Dysfunction Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.8.5.1 Japan Age-related Vision Dysfunction Market, By Drug
7.8.5.2 Japan Age-related Vision Dysfunction Market, By Dysfunction Type
7.8.5.3 Japan Age-related Vision Dysfunction Market, By Distribution Channel
7.8.6 Singapore Age-related Vision Dysfunction Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.8.6.1 Singapore Age-related Vision Dysfunction Market, By Drug
7.8.6.2 Singapore Age-related Vision Dysfunction Market, By Dysfunction Type
7.8.6.3 Singapore Age-related Vision Dysfunction Market, By Distribution Channel
7.8.7 Indonesia Age-related Vision Dysfunction Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.8.7.1 Indonesia Age-related Vision Dysfunction Market, By Drug
7.8.7.2 Indonesia Age-related Vision Dysfunction Market, By Dysfunction Type
7.8.7.3 Indonesia Age-related Vision Dysfunction Market, By Distribution Channel
7.8.8 Rest of Asia Pacific Age-related Vision Dysfunction Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.8.8.1 Rest of Asia Pacific Age-related Vision Dysfunction Market, By Drug
7.8.8.2 Rest of Asia Pacific Age-related Vision Dysfunction Market, By Dysfunction Type
7.8.8.3 Rest of Asia Pacific Age-related Vision Dysfunction Market, By Distribution Channel
8. Middle East & Africa Age-related Vision Dysfunction Market: Historic and Forecast
8.1 Middle East & Africa Age-related Vision Dysfunction Market: Snapshot
8.2 Middle East & Africa Age-related Vision Dysfunction Market: Market Size and CAGR, By Value, 2020-2030 (USD Million & CAGR)
8.3 Middle East & Africa Age-related Vision Dysfunction Market: Key Factors
8.4 Middle East and Africa Age-related Vision Dysfunction Market: Segment Analysis
8.5 Middle East & Africa Age-related Vision Dysfunction Market Segmentation: By Drug
8.5.1 Middle East & Africa Age-related Vision Dysfunction Market, By Drug Overview
8.5.2 Middle East & Africa Age-related Vision Dysfunction Market Size, By Eylea, By Value, 2020H-2030F (USD Million & CAGR)
8.5.3 Middle East & Africa Age-related Vision Dysfunction Market Size, By Lucentis, By Value, 2020H-2030F (USD Million & CAGR)
8.5.4 Middle East & Africa Age-related Vision Dysfunction Market Size, By Combigan, By Value, 2020H-2030F (USD Million & CAGR)
8.5.5 Middle East & Africa Age-related Vision Dysfunction Market Size, By Beovu, By Value, 2020H-2030F (USD Million & CAGR)
8.5.6 Middle East & Africa Age-related Vision Dysfunction Market Size, By Other Drugs, By Value, 2020H-2030F (USD Million & CAGR)
8.6 Middle East & Africa Age-related Vision Dysfunction Market Segmentation: By Dysfunction Type
8.6.1 Middle East & Africa Age-related Vision Dysfunction Market, By Dysfunction Type Overview
8.6.2 Middle East & Africa Age-related Vision Dysfunction Market Size, By Glaucoma, By Value, 2020H-2030F (USD Million & CAGR)
8.6.3 Middle East & Africa Age-related Vision Dysfunction Market Size, By Cataract, By Value, 2020H-2030F (USD Million & CAGR)
8.6.4 Middle East & Africa Age-related Vision Dysfunction Market Size, By Presbyopia, By Value, 2020H-2030F (USD Million & CAGR)
8.6.5 Middle East & Africa Age-related Vision Dysfunction Market Size, By AMD, By Value, 2020H-2030F (USD Million & CAGR)
8.7 Middle East & Africa Age-related Vision Dysfunction Market Segmentation: By Distribution Channel
8.7.1 Middle East & Africa Age-related Vision Dysfunction Market, By Distribution Channel Overview
8.7.2 Middle East & Africa Age-related Vision Dysfunction Market Size, By Online Pharmacies, By Value, 2020H-2030F (USD Million & CAGR)
8.7.3 Middle East & Africa Age-related Vision Dysfunction Market Size, By Retail Pharmacies , By Value, 2020H-2030F (USD Million & CAGR)
8.8 Middle East & Africa Age-related Vision Dysfunction Market Segmentation: By Country
8.8.1 Middle East & Africa Age-related Vision Dysfunction Market, by Country Overview
8.8.2 GCC Age-related Vision Dysfunction Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
8.8.2.1 GCC Age-related Vision Dysfunction Market, By Drug
8.8.2.2 GCC Age-related Vision Dysfunction Market, By Dysfunction Type
8.8.2.3 GCC Age-related Vision Dysfunction Market, By Distribution Channel
8.8.3 Israel Age-related Vision Dysfunction Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
8.8.3.1 Israel Age-related Vision Dysfunction Market, By Drug
8.8.3.2 Israel Age-related Vision Dysfunction Market, By Dysfunction Type
8.8.3.3 Israel Age-related Vision Dysfunction Market, By Distribution Channel
8.8.4 South Africa Age-related Vision Dysfunction Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
8.8.4.1 South Africa Age-related Vision Dysfunction Market, By Drug
8.8.4.2 South Africa Age-related Vision Dysfunction Market, By Dysfunction Type
8.8.4.3 South Africa Age-related Vision Dysfunction Market, By Distribution Channel
8.8.5 Rest of Middle East and Africa Age-related Vision Dysfunction Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
8.8.5.1 Rest of Middle East and Africa Age-related Vision Dysfunction Market, By Drug
8.8.5.2 Rest of Middle East and Africa Age-related Vision Dysfunction Market, By Dysfunction Type
8.8.5.3 Rest of Middle East and Africa Age-related Vision Dysfunction Market, By Distribution Channel
8.2 Middle East & Africa Age-related Vision Dysfunction Market: Market Size and CAGR, By Value, 2020-2030 (USD Million & CAGR)
8.3 Middle East & Africa Age-related Vision Dysfunction Market: Key Factors
8.4 Middle East and Africa Age-related Vision Dysfunction Market: Segment Analysis
8.5 Middle East & Africa Age-related Vision Dysfunction Market Segmentation: By Drug
8.5.1 Middle East & Africa Age-related Vision Dysfunction Market, By Drug Overview
8.5.2 Middle East & Africa Age-related Vision Dysfunction Market Size, By Eylea, By Value, 2020H-2030F (USD Million & CAGR)
8.5.3 Middle East & Africa Age-related Vision Dysfunction Market Size, By Lucentis, By Value, 2020H-2030F (USD Million & CAGR)
8.5.4 Middle East & Africa Age-related Vision Dysfunction Market Size, By Combigan, By Value, 2020H-2030F (USD Million & CAGR)
8.5.5 Middle East & Africa Age-related Vision Dysfunction Market Size, By Beovu, By Value, 2020H-2030F (USD Million & CAGR)
8.5.6 Middle East & Africa Age-related Vision Dysfunction Market Size, By Other Drugs, By Value, 2020H-2030F (USD Million & CAGR)
8.6 Middle East & Africa Age-related Vision Dysfunction Market Segmentation: By Dysfunction Type
8.6.1 Middle East & Africa Age-related Vision Dysfunction Market, By Dysfunction Type Overview
8.6.2 Middle East & Africa Age-related Vision Dysfunction Market Size, By Glaucoma, By Value, 2020H-2030F (USD Million & CAGR)
8.6.3 Middle East & Africa Age-related Vision Dysfunction Market Size, By Cataract, By Value, 2020H-2030F (USD Million & CAGR)
8.6.4 Middle East & Africa Age-related Vision Dysfunction Market Size, By Presbyopia, By Value, 2020H-2030F (USD Million & CAGR)
8.6.5 Middle East & Africa Age-related Vision Dysfunction Market Size, By AMD, By Value, 2020H-2030F (USD Million & CAGR)
8.7 Middle East & Africa Age-related Vision Dysfunction Market Segmentation: By Distribution Channel
8.7.1 Middle East & Africa Age-related Vision Dysfunction Market, By Distribution Channel Overview
8.7.2 Middle East & Africa Age-related Vision Dysfunction Market Size, By Online Pharmacies, By Value, 2020H-2030F (USD Million & CAGR)
8.7.3 Middle East & Africa Age-related Vision Dysfunction Market Size, By Retail Pharmacies , By Value, 2020H-2030F (USD Million & CAGR)
8.8 Middle East & Africa Age-related Vision Dysfunction Market Segmentation: By Country
8.8.1 Middle East & Africa Age-related Vision Dysfunction Market, by Country Overview
8.8.2 GCC Age-related Vision Dysfunction Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
8.8.2.1 GCC Age-related Vision Dysfunction Market, By Drug
8.8.2.2 GCC Age-related Vision Dysfunction Market, By Dysfunction Type
8.8.2.3 GCC Age-related Vision Dysfunction Market, By Distribution Channel
8.8.3 Israel Age-related Vision Dysfunction Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
8.8.3.1 Israel Age-related Vision Dysfunction Market, By Drug
8.8.3.2 Israel Age-related Vision Dysfunction Market, By Dysfunction Type
8.8.3.3 Israel Age-related Vision Dysfunction Market, By Distribution Channel
8.8.4 South Africa Age-related Vision Dysfunction Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
8.8.4.1 South Africa Age-related Vision Dysfunction Market, By Drug
8.8.4.2 South Africa Age-related Vision Dysfunction Market, By Dysfunction Type
8.8.4.3 South Africa Age-related Vision Dysfunction Market, By Distribution Channel
8.8.5 Rest of Middle East and Africa Age-related Vision Dysfunction Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
8.8.5.1 Rest of Middle East and Africa Age-related Vision Dysfunction Market, By Drug
8.8.5.2 Rest of Middle East and Africa Age-related Vision Dysfunction Market, By Dysfunction Type
8.8.5.3 Rest of Middle East and Africa Age-related Vision Dysfunction Market, By Distribution Channel
9. Market Dynamics
9.1 Impact assessment of Market Dynamics on Age-related Vision Dysfunction Market
9.2 Drivers
9.3 Restraints
9.4 Trends
9.2 Drivers
9.3 Restraints
9.4 Trends
10. Ecosystem Analysis
10.1 Porter Analysis
11. Competitive Positioning
11.1 Companies’ Competitive Positioning
11.2 Market Position Matrix
11.3 Market Share Analysis of Age-related Vision Dysfunction Market
11.4 Company Profiles
11.4.1 Bausch + Lomb
11.4.2 D Western Therapeutics Institute
11.4.3 Novartis
11.4.4 IVERIC Bio
11.4.5 Santen Pharmaceutical
11.4.6 AbbVie
11.4.7 Aerie Pharmaceuticals
11.4.8 Eyenovia
11.4.9 Sun Pharma Advanced Research Company Limited
11.4.10 Orasis Pharmaceuticals
11.4.11 Other Leading Companies
11.2 Market Position Matrix
11.3 Market Share Analysis of Age-related Vision Dysfunction Market
11.4 Company Profiles
11.4.1 Bausch + Lomb
11.4.2 D Western Therapeutics Institute
11.4.3 Novartis
11.4.4 IVERIC Bio
11.4.5 Santen Pharmaceutical
11.4.6 AbbVie
11.4.7 Aerie Pharmaceuticals
11.4.8 Eyenovia
11.4.9 Sun Pharma Advanced Research Company Limited
11.4.10 Orasis Pharmaceuticals
11.4.11 Other Leading Companies
List of Figures
Figure 1: Age-related Vision Dysfunction Market, Comparison of Leading Countries, 2023 (%)
Figure 2: Age-related Vision Dysfunction Market, Comparison of Leading Countries, 2030 (%)
Figure 3: Age-related Vision Dysfunction Market Type Matrix
Figure 4: Age-related Vision Dysfunction Market Demand Analysis
Figure 5: Global Age-related Vision Dysfunction Market Size, By Value, 2020-2023 (USD Million)
Figure 6: Global Age-related Vision Dysfunction Market Size, By Value, 2024-2030 (USD Million)
Figure 7: Global Age-related Vision Dysfunction Market Share, By Dysfunction Type, 2023 (%)
Figure 8: Global Age-related Vision Dysfunction Market CAGR, 2020-2023 (%)
Figure 9: Global Age-related Vision Dysfunction Market CAGR, 2025-2030 (%)
Figure 10: Global Age-related Vision Dysfunction Market CAGR (%), By Region, 2020-2023, 2025-2030
Figure 11: Market Attractiveness Analysis of Global Age-related Vision Dysfunction Market, By Drug (2025-2030)
Figure 12: Global Age-related Vision Dysfunction Market Size, By Eylea, By Value, 2020H-2030F (USD Million & CAGR)
Figure 13: Global Age-related Vision Dysfunction Market Absolute Opportunity, By Eylea, 2020-2030 (USD Million)
Figure 14: Global Age-related Vision Dysfunction Market Size, By Lucentis, By Value, 2020H-2030F (USD Million & CAGR)
Figure 15: Global Age-related Vision Dysfunction Market Absolute Opportunity, By Lucentis, 2020-2030 (USD Million)
Figure 16: Global Age-related Vision Dysfunction Market Size, By Combigan, By Value, 2020H-2030F (USD Million & CAGR)
Figure 17: Global Age-related Vision Dysfunction Market Absolute Opportunity, By Combigan, 2020-2030 (USD Million)
Figure 18: Global Age-related Vision Dysfunction Market Size, By Beovu, By Value, 2020H-2030F (USD Million & CAGR)
Figure 19: Global Age-related Vision Dysfunction Market Absolute Opportunity, By Beovu, 2020-2030 (USD Million)
Figure 20: Global Age-related Vision Dysfunction Market Size, By Other Drugs, By Value, 2020H-2030F (USD Million & CAGR)
Figure 21: Global Age-related Vision Dysfunction Market Absolute Opportunity, By Other Drugs, 2020-2030 (USD Million)
Figure 22: Market Attractiveness Analysis of Global Age-related Vision Dysfunction Market, By Dysfunction Type (2025-2030)
Figure 23: Global Age-related Vision Dysfunction Market Size, By Glaucoma, By Value, 2020H-2030F (USD Million & CAGR)
Figure 24: Global Age-related Vision Dysfunction Market Absolute Opportunity, By Glaucoma, 2020-2030 (USD Million)
Figure 25: Global Age-related Vision Dysfunction Market Size, By Cataract, By Value, 2020H-2030F (USD Million & CAGR)
Figure 26: Global Age-related Vision Dysfunction Market Absolute Opportunity, By Cataract, 2020-2030 (USD Million)
Figure 27: Global Age-related Vision Dysfunction Market Size, By Presbyopia, By Value, 2020H-2030F (USD Million & CAGR)
Figure 28: Global Age-related Vision Dysfunction Market Absolute Opportunity, By Presbyopia, 2020-2030 (USD Million)
Figure 29: Global Age-related Vision Dysfunction Market Size, By AMD, By Value, 2020H-2030F (USD Million & CAGR)
Figure 30: Global Age-related Vision Dysfunction Market Absolute Opportunity, By AMD, 2020-2030 (USD Million)
Figure 31: Market Attractiveness Analysis of Global Age-related Vision Dysfunction Market, By Distribution Channel (2025-2030)
Figure 32: Global Age-related Vision Dysfunction Market Size, By Online Pharmacies, By Value, 2020H-2030F (USD Million & CAGR)
Figure 33: Global Age-related Vision Dysfunction Market Absolute Opportunity, By Online Pharmacies, 2020-2030 (USD Million)
Figure 34: Global Age-related Vision Dysfunction Market Size, By Retail Pharmacies , By Value, 2020H-2030F (USD Million & CAGR)
Figure 35: Global Age-related Vision Dysfunction Market Absolute Opportunity, By Retail Pharmacies , 2020-2030 (USD Million)
Figure 36: Americas Age-related Vision Dysfunction Market Size, By Value, 2020H-2030F (USD Million)
Figure 37: Americas Age-related Vision Dysfunction Market Share, By Dysfunction Type, 2023 (%)
Figure 38: Americas Age-related Vision Dysfunction Market Share, By New Product Launches, 2023 (%)
Figure 39: Americas Age-related Vision Dysfunction Market Share, By Company, 2023 (%)
Figure 40: Americas Age-related Vision Dysfunction Market CAGR (%), By Region, 2020-2023, 2025-2030
Figure 41: Americas Age-related Vision Dysfunction Market, By Eylea, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 42: Americas Age-related Vision Dysfunction Market, By Lucentis, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 43: Americas Age-related Vision Dysfunction Market, By Combigan, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 44: Americas Age-related Vision Dysfunction Market, By Beovu, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 45: Americas Age-related Vision Dysfunction Market, By Other Drugs, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 46: Figure 46: Americas Age-related Vision Dysfunction Market, By Glaucoma, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 47: Americas Age-related Vision Dysfunction Market, By Cataract, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 48: Americas Age-related Vision Dysfunction Market, By Combigan, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 49: Americas Age-related Vision Dysfunction Market, By AMD, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 50: Americas Age-related Vision Dysfunction Market, By Online Pharmacies, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 51: Americas Age-related Vision Dysfunction Market, By Retail Pharmacies , By Value, 2020H-2030F (USD Millions & CAGR)
Figure 52: United States Age-related Vision Dysfunction Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 53: United States Age-related Vision Dysfunction Market Value, By Distribution Channel, 2023 (USD Million)
Figure 54: United States Age-related Vision Dysfunction Market Share, By Drug, By Value, 2023 (%)
Figure 55: United States Age-related Vision Dysfunction Market Share, By Dysfunction Type, By Value, 2023 (%)
Figure 56: United States Age-related Vision Dysfunction Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 57: Canada Age-related Vision Dysfunction Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 58: Canada Age-related Vision Dysfunction Market Value, By Distribution Channel, 2023 (USD Million)
Figure 59: Canada Age-related Vision Dysfunction Market Share, By Drug, By Value, 2023 (%)
Figure 60: Canada Age-related Vision Dysfunction Market Share, By Dysfunction Type, By Value, 2023 (%)
Figure 61: Canada Age-related Vision Dysfunction Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 62: Brazil Age-related Vision Dysfunction Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 63: Brazil Age-related Vision Dysfunction Market Value, By Distribution Channel, 2023 (USD Million)
Figure 64: Brazil Age-related Vision Dysfunction Market Share, By Drug, By Value, 2023 (%)
Figure 65: Brazil Age-related Vision Dysfunction Market Share, By Dysfunction Type, By Value, 2023 (%)
Figure 66: Brazil Age-related Vision Dysfunction Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 67: Mexico Age-related Vision Dysfunction Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 68: Mexico Age-related Vision Dysfunction Market Value, By Distribution Channel, 2023 (USD Million)
Figure 69: Mexico Age-related Vision Dysfunction Market Share, By Drug, By Value, 2023 (%)
Figure 70: Mexico Age-related Vision Dysfunction Market Share, By Dysfunction Type, By Value, 2023 (%)
Figure 71: Mexico Age-related Vision Dysfunction Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 72: Rest of Americas Age-related Vision Dysfunction Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 73: Rest of Americas Age-related Vision Dysfunction Market Value, By Distribution Channel, 2023 (USD Million)
Figure 74: Rest of Americas Age-related Vision Dysfunction Market Share, By Drug, By Value, 2023 (%)
Figure 75: Rest of Americas Age-related Vision Dysfunction Market Share, By Dysfunction Type, By Value, 2023 (%)
Figure 76: Rest of Americas Age-related Vision Dysfunction Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 77: Europe Age-related Vision Dysfunction Market Size, By Value, 2020H-2030F (USD Million)
Figure 78: Europe Age-related Vision Dysfunction Market Share, By Dysfunction Type, 2023 (%)
Figure 79: Europe Age-related Vision Dysfunction Market Share, By New Product Launches, 2023 (%)
Figure 80: Europe Age-related Vision Dysfunction Market Share, By Company, 2023 (%)
Figure 81: Europe Age-related Vision Dysfunction Market CAGR (%), By Region, 2020-2023, 2025-2030
Figure 82: Europe Age-related Vision Dysfunction Market, By Eylea, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 83: Europe Age-related Vision Dysfunction Market, By Lucentis, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 84: Europe Age-related Vision Dysfunction Market, By Combigan, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 85: Europe Age-related Vision Dysfunction Market, By Beovu, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 86: Europe Age-related Vision Dysfunction Market, By Other Drugs, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 87: Europe Age-related Vision Dysfunction Market, By Glaucoma, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 88: Europe Age-related Vision Dysfunction Market, By Cataract, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 89: Europe Age-related Vision Dysfunction Market, By Presbyopia, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 90: Europe Age-related Vision Dysfunction Market, By AMD, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 91: Europe Age-related Vision Dysfunction Market, By Online Pharmacies, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 92: Europe Age-related Vision Dysfunction Market, By Retail Pharmacies , By Value, 2020H-2030F (USD Millions & CAGR)
Figure 93: Russia Age-related Vision Dysfunction Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 94: Russia Age-related Vision Dysfunction Market Value, By Distribution Channel, 2023 (USD Million)
Figure 95: Russia Age-related Vision Dysfunction Market Share, By Drug, By Value, 2023 (%)
Figure 96: Russia Age-related Vision Dysfunction Market Share, By Dysfunction Type, By Value, 2023 (%)
Figure 97: Russia Age-related Vision Dysfunction Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 98: France Age-related Vision Dysfunction Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 99: France Age-related Vision Dysfunction Market Value, By Distribution Channel, 2023 (USD Million)
Figure 100: France Age-related Vision Dysfunction Market Share, By Drug, By Value, 2023 (%)
Figure 101: France Age-related Vision Dysfunction Market Share, By Dysfunction Type, By Value, 2023 (%)
Figure 102: France Age-related Vision Dysfunction Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 103: United Kingdom Age-related Vision Dysfunction Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 104: United Kingdom Age-related Vision Dysfunction Market Value, By Distribution Channel, 2023 (USD Million)
Figure 105: United Kingdom Age-related Vision Dysfunction Market Share, By Drug, By Value, 2023 (%)
Figure 106: United Kingdom Age-related Vision Dysfunction Market Share, By Dysfunction Type, By Value, 2023 (%)
Figure 107: United Kingdom Age-related Vision Dysfunction Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 108: Germany Age-related Vision Dysfunction Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 109: Germany Age-related Vision Dysfunction Market Value, By Distribution Channel, 2023 (USD Million)
Figure 110: Germany Age-related Vision Dysfunction Market Share, By Drug, By Value, 2023 (%)
Figure 111: Germany Age-related Vision Dysfunction Market Share, By Dysfunction Type, By Value, 2023 (%)
Figure 112: Germany Age-related Vision Dysfunction Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 113: Italy Age-related Vision Dysfunction Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 114: Italy Age-related Vision Dysfunction Market Value, By Distribution Channel, 2023 (USD Million)
Figure 115: Italy Age-related Vision Dysfunction Market Share, By Drug, By Value, 2023 (%)
Figure 116: Italy Age-related Vision Dysfunction Market Share, By Dysfunction Type, By Value, 2023 (%)
Figure 117: Italy Age-related Vision Dysfunction Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 118: Spain Age-related Vision Dysfunction Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 119: Spain Age-related Vision Dysfunction Market Value, By Distribution Channel, 2023 (USD Million)
Figure 120: Spain Age-related Vision Dysfunction Market Share, By Drug, By Value, 2023 (%)
Figure 121: Spain Age-related Vision Dysfunction Market Share, By Dysfunction Type, By Value, 2023 (%)
Figure 122: Spain Age-related Vision Dysfunction Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 123: Turkey Age-related Vision Dysfunction Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 124: Turkey Age-related Vision Dysfunction Market Value, By Distribution Channel, 2023 (USD Million)
Figure 125: Turkey Age-related Vision Dysfunction Market Share, By Drug, By Value, 2023 (%)
Figure 126: Turkey Age-related Vision Dysfunction Market Share, By Dysfunction Type, By Value, 2023 (%)
Figure 127: Turkey Age-related Vision Dysfunction Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 128: Rest of Europe Age-related Vision Dysfunction Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 129: Rest of Europe Age-related Vision Dysfunction Market Value, By Distribution Channel, 2023 (USD Million)
Figure 130: Rest of Europe Age-related Vision Dysfunction Market Share, By Drug, By Value, 2023 (%)
Figure 131: Rest of Europe Age-related Vision Dysfunction Market Share, By Dysfunction Type, By Value, 2023 (%)
Figure 132: Rest of Europe Age-related Vision Dysfunction Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 133: Asia Pacific Age-related Vision Dysfunction Market Size, By Value, 2020H-2030F (USD Million)
Figure 134: Asia Pacific Age-related Vision Dysfunction Market Share, By Dysfunction Type, 2023 (%)
Figure 135: Asia Pacific Age-related Vision Dysfunction Market Share, By New Product Launches, 2023 (%)
Figure 136: Asia Pacific Age-related Vision Dysfunction Market Share, By Company, 2023 (%)
Figure 137: Asia Pacific Age-related Vision Dysfunction Market CAGR (%), By Region, 2020-2023, 2025-2030
Figure 138: Asia Pacific Age-related Vision Dysfunction Market, By Eylea, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 139: Asia Pacific Age-related Vision Dysfunction Market, By Lucentis, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 140: Asia Pacific Age-related Vision Dysfunction Market, By Combigan, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 141: Asia Pacific Age-related Vision Dysfunction Market, By Beovu, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 142: Asia Pacific Age-related Vision Dysfunction Market, By Other Drugs, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 143: Asia Pacific Age-related Vision Dysfunction Market, By Glaucoma, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 144: Asia Pacific Age-related Vision Dysfunction Market, By Cataract, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 145: Asia Pacific Age-related Vision Dysfunction Market, By Presbyopia, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 146: Asia Pacific Age-related Vision Dysfunction Market, By AMD, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 147: Asia Pacific Age-related Vision Dysfunction Market, By Online Pharmacies, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 148: Asia Pacific Age-related Vision Dysfunction Market, By Retail Pharmacies , By Value, 2020H-2030F (USD Millions & CAGR)
Figure 149: China Age-related Vision Dysfunction Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 150: China Age-related Vision Dysfunction Market Value, By Distribution Channel, 2023 (USD Million)
Figure 151: China Age-related Vision Dysfunction Market Share, By Drug, By Value, 2023 (%)
Figure 152: China Age-related Vision Dysfunction Market Share, By Dysfunction Type, By Value, 2023 (%)
Figure 153: China Age-related Vision Dysfunction Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 154: India Age-related Vision Dysfunction Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 155: India Age-related Vision Dysfunction Market Value, By Distribution Channel, 2023 (USD Million)
Figure 156: India Age-related Vision Dysfunction Market Share, By Drug, By Value, 2023 (%)
Figure 157: India Age-related Vision Dysfunction Market Share, By Dysfunction Type, By Value, 2023 (%)
Figure 158: India Age-related Vision Dysfunction Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 159: South Korea Age-related Vision Dysfunction Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 160: South Korea Age-related Vision Dysfunction Market Value, By Distribution Channel, 2023 (USD Million)
Figure 161: South Korea Age-related Vision Dysfunction Market Share, By Drug, By Value, 2023 (%)
Figure 162: South Korea Age-related Vision Dysfunction Market Share, By Dysfunction Type, By Value, 2023 (%)
Figure 163: South Korea Age-related Vision Dysfunction Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 164: Japan Age-related Vision Dysfunction Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 165: Japan Age-related Vision Dysfunction Market Value, By Distribution Channel, 2023 (USD Million)
Figure 166: Japan Age-related Vision Dysfunction Market Share, By Drug, By Value, 2023 (%)
Figure 167: Japan Age-related Vision Dysfunction Market Share, By Dysfunction Type, By Value, 2023 (%)
Figure 168: Japan Age-related Vision Dysfunction Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 169: Singapore Age-related Vision Dysfunction Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 170: Singapore Age-related Vision Dysfunction Market Value, By Distribution Channel, 2023 (USD Million)
Figure 171: Singapore Age-related Vision Dysfunction Market Share, By Drug, By Value, 2023 (%)
Figure 172: Singapore Age-related Vision Dysfunction Market Share, By Dysfunction Type, By Value, 2023 (%)
Figure 173: Singapore Age-related Vision Dysfunction Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 174: Indonesia Age-related Vision Dysfunction Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 175: Indonesia Age-related Vision Dysfunction Market Value, By Distribution Channel, 2023 (USD Million)
Figure 176: Indonesia Age-related Vision Dysfunction Market Share, By Drug, By Value, 2023 (%)
Figure 177: Indonesia Age-related Vision Dysfunction Market Share, By Dysfunction Type, By Value, 2023 (%)
Figure 178: Indonesia Age-related Vision Dysfunction Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 179: Rest of Asia Pacific Age-related Vision Dysfunction Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 180: Rest of Asia Pacific Age-related Vision Dysfunction Market Value, By Distribution Channel, 2023 (USD Million)
Figure 181: Rest of Asia Pacific Age-related Vision Dysfunction Market Share, By Drug, By Value, 2023 (%)
Figure 182: Rest of Asia Pacific Age-related Vision Dysfunction Market Share, By Dysfunction Type, By Value, 2023 (%)
Figure 183: Rest of Asia Pacific Age-related Vision Dysfunction Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 184: Middle East and Africa Age-related Vision Dysfunction Market Size, By Value, 2020H-2030F (USD Million)
Figure 185: Middle East and Africa Age-related Vision Dysfunction Market Share, By Dysfunction Type, 2023 (%)
Figure 186: Middle East and Africa Age-related Vision Dysfunction Market Share, By New Product Launches, 2023 (%)
Figure 187: Middle East and Africa Age-related Vision Dysfunction Market Share, By Company, 2023 (%)
Figure 188: Middle East and Africa Age-related Vision Dysfunction Market CAGR (%), By Region, 2020-2023, 2025-2030
Figure 189: Middle East and Africa Age-related Vision Dysfunction Market, By Eylea, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 190: Middle East and Africa Age-related Vision Dysfunction Market, By Lucentis, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 191: Middle East and Africa Age-related Vision Dysfunction Market, By Combigan, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 192: Middle East and Africa Age-related Vision Dysfunction Market, By Beovu, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 193: Middle East and Africa Age-related Vision Dysfunction Market, By Other Drugs, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 194: Middle East and Africa Age-related Vision Dysfunction Market, By Glaucoma, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 195: Middle East and Africa Age-related Vision Dysfunction Market, By Cataract, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 196: Middle East and Africa Age-related Vision Dysfunction Market, By Presbyopia, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 197: Middle East and Africa Age-related Vision Dysfunction Market, By AMD, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 198: Middle East and Africa Age-related Vision Dysfunction Market, By Online Pharmacies, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 199: Middle East and Africa Age-related Vision Dysfunction Market, By Retail Pharmacies , By Value, 2020H-2030F (USD Millions & CAGR)
Figure 200: GCC Age-related Vision Dysfunction Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 201: GCC Age-related Vision Dysfunction Market Value, By Distribution Channel, 2023 (USD Million)
Figure 202: GCC Age-related Vision Dysfunction Market Share, By Drug, By Value, 2023 (%)
Figure 203: GCC Age-related Vision Dysfunction Market Share, By Dysfunction Type, By Value, 2023 (%)
Figure 204: GCC Age-related Vision Dysfunction Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 205: Israel Age-related Vision Dysfunction Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 206: Israel Age-related Vision Dysfunction Market Value, By Distribution Channel, 2023 (USD Million)
Figure 207: Israel Age-related Vision Dysfunction Market Share, By Drug, By Value, 2023 (%)
Figure 208: Israel Age-related Vision Dysfunction Market Share, By Dysfunction Type, By Value, 2023 (%)
Figure 209: Israel Age-related Vision Dysfunction Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 210: South Africa Age-related Vision Dysfunction Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 211: South Africa Age-related Vision Dysfunction Market Value, By Distribution Channel, 2023 (USD Million)
Figure 212: South Africa Age-related Vision Dysfunction Market Share, By Drug, By Value, 2023 (%)
Figure 213: South Africa Age-related Vision Dysfunction Market Share, By Dysfunction Type, By Value, 2023 (%)
Figure 214: South Africa Age-related Vision Dysfunction Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 215: Rest of Middle East and Africa Age-related Vision Dysfunction Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 216: Rest of Middle East and Africa Age-related Vision Dysfunction Market Value, By Distribution Channel, 2023 (USD Million)
Figure 217: Rest of Middle East and Africa Age-related Vision Dysfunction Market Share, By Drug, By Value, 2023 (%)
Figure 218: Rest of Middle East and Africa Age-related Vision Dysfunction Market Share, By Dysfunction Type, By Value, 2023 (%)
Figure 219: Rest of Middle East and Africa Age-related Vision Dysfunction Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 220: Market Share of Prominent Companies of Global Age-related Vision Dysfunction Market, 2023 (%)
Figure 2: Age-related Vision Dysfunction Market, Comparison of Leading Countries, 2030 (%)
Figure 3: Age-related Vision Dysfunction Market Type Matrix
Figure 4: Age-related Vision Dysfunction Market Demand Analysis
Figure 5: Global Age-related Vision Dysfunction Market Size, By Value, 2020-2023 (USD Million)
Figure 6: Global Age-related Vision Dysfunction Market Size, By Value, 2024-2030 (USD Million)
Figure 7: Global Age-related Vision Dysfunction Market Share, By Dysfunction Type, 2023 (%)
Figure 8: Global Age-related Vision Dysfunction Market CAGR, 2020-2023 (%)
Figure 9: Global Age-related Vision Dysfunction Market CAGR, 2025-2030 (%)
Figure 10: Global Age-related Vision Dysfunction Market CAGR (%), By Region, 2020-2023, 2025-2030
Figure 11: Market Attractiveness Analysis of Global Age-related Vision Dysfunction Market, By Drug (2025-2030)
Figure 12: Global Age-related Vision Dysfunction Market Size, By Eylea, By Value, 2020H-2030F (USD Million & CAGR)
Figure 13: Global Age-related Vision Dysfunction Market Absolute Opportunity, By Eylea, 2020-2030 (USD Million)
Figure 14: Global Age-related Vision Dysfunction Market Size, By Lucentis, By Value, 2020H-2030F (USD Million & CAGR)
Figure 15: Global Age-related Vision Dysfunction Market Absolute Opportunity, By Lucentis, 2020-2030 (USD Million)
Figure 16: Global Age-related Vision Dysfunction Market Size, By Combigan, By Value, 2020H-2030F (USD Million & CAGR)
Figure 17: Global Age-related Vision Dysfunction Market Absolute Opportunity, By Combigan, 2020-2030 (USD Million)
Figure 18: Global Age-related Vision Dysfunction Market Size, By Beovu, By Value, 2020H-2030F (USD Million & CAGR)
Figure 19: Global Age-related Vision Dysfunction Market Absolute Opportunity, By Beovu, 2020-2030 (USD Million)
Figure 20: Global Age-related Vision Dysfunction Market Size, By Other Drugs, By Value, 2020H-2030F (USD Million & CAGR)
Figure 21: Global Age-related Vision Dysfunction Market Absolute Opportunity, By Other Drugs, 2020-2030 (USD Million)
Figure 22: Market Attractiveness Analysis of Global Age-related Vision Dysfunction Market, By Dysfunction Type (2025-2030)
Figure 23: Global Age-related Vision Dysfunction Market Size, By Glaucoma, By Value, 2020H-2030F (USD Million & CAGR)
Figure 24: Global Age-related Vision Dysfunction Market Absolute Opportunity, By Glaucoma, 2020-2030 (USD Million)
Figure 25: Global Age-related Vision Dysfunction Market Size, By Cataract, By Value, 2020H-2030F (USD Million & CAGR)
Figure 26: Global Age-related Vision Dysfunction Market Absolute Opportunity, By Cataract, 2020-2030 (USD Million)
Figure 27: Global Age-related Vision Dysfunction Market Size, By Presbyopia, By Value, 2020H-2030F (USD Million & CAGR)
Figure 28: Global Age-related Vision Dysfunction Market Absolute Opportunity, By Presbyopia, 2020-2030 (USD Million)
Figure 29: Global Age-related Vision Dysfunction Market Size, By AMD, By Value, 2020H-2030F (USD Million & CAGR)
Figure 30: Global Age-related Vision Dysfunction Market Absolute Opportunity, By AMD, 2020-2030 (USD Million)
Figure 31: Market Attractiveness Analysis of Global Age-related Vision Dysfunction Market, By Distribution Channel (2025-2030)
Figure 32: Global Age-related Vision Dysfunction Market Size, By Online Pharmacies, By Value, 2020H-2030F (USD Million & CAGR)
Figure 33: Global Age-related Vision Dysfunction Market Absolute Opportunity, By Online Pharmacies, 2020-2030 (USD Million)
Figure 34: Global Age-related Vision Dysfunction Market Size, By Retail Pharmacies , By Value, 2020H-2030F (USD Million & CAGR)
Figure 35: Global Age-related Vision Dysfunction Market Absolute Opportunity, By Retail Pharmacies , 2020-2030 (USD Million)
Figure 36: Americas Age-related Vision Dysfunction Market Size, By Value, 2020H-2030F (USD Million)
Figure 37: Americas Age-related Vision Dysfunction Market Share, By Dysfunction Type, 2023 (%)
Figure 38: Americas Age-related Vision Dysfunction Market Share, By New Product Launches, 2023 (%)
Figure 39: Americas Age-related Vision Dysfunction Market Share, By Company, 2023 (%)
Figure 40: Americas Age-related Vision Dysfunction Market CAGR (%), By Region, 2020-2023, 2025-2030
Figure 41: Americas Age-related Vision Dysfunction Market, By Eylea, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 42: Americas Age-related Vision Dysfunction Market, By Lucentis, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 43: Americas Age-related Vision Dysfunction Market, By Combigan, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 44: Americas Age-related Vision Dysfunction Market, By Beovu, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 45: Americas Age-related Vision Dysfunction Market, By Other Drugs, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 46: Figure 46: Americas Age-related Vision Dysfunction Market, By Glaucoma, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 47: Americas Age-related Vision Dysfunction Market, By Cataract, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 48: Americas Age-related Vision Dysfunction Market, By Combigan, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 49: Americas Age-related Vision Dysfunction Market, By AMD, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 50: Americas Age-related Vision Dysfunction Market, By Online Pharmacies, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 51: Americas Age-related Vision Dysfunction Market, By Retail Pharmacies , By Value, 2020H-2030F (USD Millions & CAGR)
Figure 52: United States Age-related Vision Dysfunction Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 53: United States Age-related Vision Dysfunction Market Value, By Distribution Channel, 2023 (USD Million)
Figure 54: United States Age-related Vision Dysfunction Market Share, By Drug, By Value, 2023 (%)
Figure 55: United States Age-related Vision Dysfunction Market Share, By Dysfunction Type, By Value, 2023 (%)
Figure 56: United States Age-related Vision Dysfunction Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 57: Canada Age-related Vision Dysfunction Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 58: Canada Age-related Vision Dysfunction Market Value, By Distribution Channel, 2023 (USD Million)
Figure 59: Canada Age-related Vision Dysfunction Market Share, By Drug, By Value, 2023 (%)
Figure 60: Canada Age-related Vision Dysfunction Market Share, By Dysfunction Type, By Value, 2023 (%)
Figure 61: Canada Age-related Vision Dysfunction Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 62: Brazil Age-related Vision Dysfunction Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 63: Brazil Age-related Vision Dysfunction Market Value, By Distribution Channel, 2023 (USD Million)
Figure 64: Brazil Age-related Vision Dysfunction Market Share, By Drug, By Value, 2023 (%)
Figure 65: Brazil Age-related Vision Dysfunction Market Share, By Dysfunction Type, By Value, 2023 (%)
Figure 66: Brazil Age-related Vision Dysfunction Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 67: Mexico Age-related Vision Dysfunction Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 68: Mexico Age-related Vision Dysfunction Market Value, By Distribution Channel, 2023 (USD Million)
Figure 69: Mexico Age-related Vision Dysfunction Market Share, By Drug, By Value, 2023 (%)
Figure 70: Mexico Age-related Vision Dysfunction Market Share, By Dysfunction Type, By Value, 2023 (%)
Figure 71: Mexico Age-related Vision Dysfunction Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 72: Rest of Americas Age-related Vision Dysfunction Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 73: Rest of Americas Age-related Vision Dysfunction Market Value, By Distribution Channel, 2023 (USD Million)
Figure 74: Rest of Americas Age-related Vision Dysfunction Market Share, By Drug, By Value, 2023 (%)
Figure 75: Rest of Americas Age-related Vision Dysfunction Market Share, By Dysfunction Type, By Value, 2023 (%)
Figure 76: Rest of Americas Age-related Vision Dysfunction Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 77: Europe Age-related Vision Dysfunction Market Size, By Value, 2020H-2030F (USD Million)
Figure 78: Europe Age-related Vision Dysfunction Market Share, By Dysfunction Type, 2023 (%)
Figure 79: Europe Age-related Vision Dysfunction Market Share, By New Product Launches, 2023 (%)
Figure 80: Europe Age-related Vision Dysfunction Market Share, By Company, 2023 (%)
Figure 81: Europe Age-related Vision Dysfunction Market CAGR (%), By Region, 2020-2023, 2025-2030
Figure 82: Europe Age-related Vision Dysfunction Market, By Eylea, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 83: Europe Age-related Vision Dysfunction Market, By Lucentis, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 84: Europe Age-related Vision Dysfunction Market, By Combigan, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 85: Europe Age-related Vision Dysfunction Market, By Beovu, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 86: Europe Age-related Vision Dysfunction Market, By Other Drugs, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 87: Europe Age-related Vision Dysfunction Market, By Glaucoma, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 88: Europe Age-related Vision Dysfunction Market, By Cataract, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 89: Europe Age-related Vision Dysfunction Market, By Presbyopia, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 90: Europe Age-related Vision Dysfunction Market, By AMD, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 91: Europe Age-related Vision Dysfunction Market, By Online Pharmacies, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 92: Europe Age-related Vision Dysfunction Market, By Retail Pharmacies , By Value, 2020H-2030F (USD Millions & CAGR)
Figure 93: Russia Age-related Vision Dysfunction Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 94: Russia Age-related Vision Dysfunction Market Value, By Distribution Channel, 2023 (USD Million)
Figure 95: Russia Age-related Vision Dysfunction Market Share, By Drug, By Value, 2023 (%)
Figure 96: Russia Age-related Vision Dysfunction Market Share, By Dysfunction Type, By Value, 2023 (%)
Figure 97: Russia Age-related Vision Dysfunction Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 98: France Age-related Vision Dysfunction Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 99: France Age-related Vision Dysfunction Market Value, By Distribution Channel, 2023 (USD Million)
Figure 100: France Age-related Vision Dysfunction Market Share, By Drug, By Value, 2023 (%)
Figure 101: France Age-related Vision Dysfunction Market Share, By Dysfunction Type, By Value, 2023 (%)
Figure 102: France Age-related Vision Dysfunction Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 103: United Kingdom Age-related Vision Dysfunction Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 104: United Kingdom Age-related Vision Dysfunction Market Value, By Distribution Channel, 2023 (USD Million)
Figure 105: United Kingdom Age-related Vision Dysfunction Market Share, By Drug, By Value, 2023 (%)
Figure 106: United Kingdom Age-related Vision Dysfunction Market Share, By Dysfunction Type, By Value, 2023 (%)
Figure 107: United Kingdom Age-related Vision Dysfunction Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 108: Germany Age-related Vision Dysfunction Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 109: Germany Age-related Vision Dysfunction Market Value, By Distribution Channel, 2023 (USD Million)
Figure 110: Germany Age-related Vision Dysfunction Market Share, By Drug, By Value, 2023 (%)
Figure 111: Germany Age-related Vision Dysfunction Market Share, By Dysfunction Type, By Value, 2023 (%)
Figure 112: Germany Age-related Vision Dysfunction Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 113: Italy Age-related Vision Dysfunction Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 114: Italy Age-related Vision Dysfunction Market Value, By Distribution Channel, 2023 (USD Million)
Figure 115: Italy Age-related Vision Dysfunction Market Share, By Drug, By Value, 2023 (%)
Figure 116: Italy Age-related Vision Dysfunction Market Share, By Dysfunction Type, By Value, 2023 (%)
Figure 117: Italy Age-related Vision Dysfunction Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 118: Spain Age-related Vision Dysfunction Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 119: Spain Age-related Vision Dysfunction Market Value, By Distribution Channel, 2023 (USD Million)
Figure 120: Spain Age-related Vision Dysfunction Market Share, By Drug, By Value, 2023 (%)
Figure 121: Spain Age-related Vision Dysfunction Market Share, By Dysfunction Type, By Value, 2023 (%)
Figure 122: Spain Age-related Vision Dysfunction Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 123: Turkey Age-related Vision Dysfunction Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 124: Turkey Age-related Vision Dysfunction Market Value, By Distribution Channel, 2023 (USD Million)
Figure 125: Turkey Age-related Vision Dysfunction Market Share, By Drug, By Value, 2023 (%)
Figure 126: Turkey Age-related Vision Dysfunction Market Share, By Dysfunction Type, By Value, 2023 (%)
Figure 127: Turkey Age-related Vision Dysfunction Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 128: Rest of Europe Age-related Vision Dysfunction Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 129: Rest of Europe Age-related Vision Dysfunction Market Value, By Distribution Channel, 2023 (USD Million)
Figure 130: Rest of Europe Age-related Vision Dysfunction Market Share, By Drug, By Value, 2023 (%)
Figure 131: Rest of Europe Age-related Vision Dysfunction Market Share, By Dysfunction Type, By Value, 2023 (%)
Figure 132: Rest of Europe Age-related Vision Dysfunction Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 133: Asia Pacific Age-related Vision Dysfunction Market Size, By Value, 2020H-2030F (USD Million)
Figure 134: Asia Pacific Age-related Vision Dysfunction Market Share, By Dysfunction Type, 2023 (%)
Figure 135: Asia Pacific Age-related Vision Dysfunction Market Share, By New Product Launches, 2023 (%)
Figure 136: Asia Pacific Age-related Vision Dysfunction Market Share, By Company, 2023 (%)
Figure 137: Asia Pacific Age-related Vision Dysfunction Market CAGR (%), By Region, 2020-2023, 2025-2030
Figure 138: Asia Pacific Age-related Vision Dysfunction Market, By Eylea, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 139: Asia Pacific Age-related Vision Dysfunction Market, By Lucentis, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 140: Asia Pacific Age-related Vision Dysfunction Market, By Combigan, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 141: Asia Pacific Age-related Vision Dysfunction Market, By Beovu, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 142: Asia Pacific Age-related Vision Dysfunction Market, By Other Drugs, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 143: Asia Pacific Age-related Vision Dysfunction Market, By Glaucoma, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 144: Asia Pacific Age-related Vision Dysfunction Market, By Cataract, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 145: Asia Pacific Age-related Vision Dysfunction Market, By Presbyopia, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 146: Asia Pacific Age-related Vision Dysfunction Market, By AMD, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 147: Asia Pacific Age-related Vision Dysfunction Market, By Online Pharmacies, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 148: Asia Pacific Age-related Vision Dysfunction Market, By Retail Pharmacies , By Value, 2020H-2030F (USD Millions & CAGR)
Figure 149: China Age-related Vision Dysfunction Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 150: China Age-related Vision Dysfunction Market Value, By Distribution Channel, 2023 (USD Million)
Figure 151: China Age-related Vision Dysfunction Market Share, By Drug, By Value, 2023 (%)
Figure 152: China Age-related Vision Dysfunction Market Share, By Dysfunction Type, By Value, 2023 (%)
Figure 153: China Age-related Vision Dysfunction Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 154: India Age-related Vision Dysfunction Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 155: India Age-related Vision Dysfunction Market Value, By Distribution Channel, 2023 (USD Million)
Figure 156: India Age-related Vision Dysfunction Market Share, By Drug, By Value, 2023 (%)
Figure 157: India Age-related Vision Dysfunction Market Share, By Dysfunction Type, By Value, 2023 (%)
Figure 158: India Age-related Vision Dysfunction Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 159: South Korea Age-related Vision Dysfunction Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 160: South Korea Age-related Vision Dysfunction Market Value, By Distribution Channel, 2023 (USD Million)
Figure 161: South Korea Age-related Vision Dysfunction Market Share, By Drug, By Value, 2023 (%)
Figure 162: South Korea Age-related Vision Dysfunction Market Share, By Dysfunction Type, By Value, 2023 (%)
Figure 163: South Korea Age-related Vision Dysfunction Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 164: Japan Age-related Vision Dysfunction Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 165: Japan Age-related Vision Dysfunction Market Value, By Distribution Channel, 2023 (USD Million)
Figure 166: Japan Age-related Vision Dysfunction Market Share, By Drug, By Value, 2023 (%)
Figure 167: Japan Age-related Vision Dysfunction Market Share, By Dysfunction Type, By Value, 2023 (%)
Figure 168: Japan Age-related Vision Dysfunction Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 169: Singapore Age-related Vision Dysfunction Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 170: Singapore Age-related Vision Dysfunction Market Value, By Distribution Channel, 2023 (USD Million)
Figure 171: Singapore Age-related Vision Dysfunction Market Share, By Drug, By Value, 2023 (%)
Figure 172: Singapore Age-related Vision Dysfunction Market Share, By Dysfunction Type, By Value, 2023 (%)
Figure 173: Singapore Age-related Vision Dysfunction Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 174: Indonesia Age-related Vision Dysfunction Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 175: Indonesia Age-related Vision Dysfunction Market Value, By Distribution Channel, 2023 (USD Million)
Figure 176: Indonesia Age-related Vision Dysfunction Market Share, By Drug, By Value, 2023 (%)
Figure 177: Indonesia Age-related Vision Dysfunction Market Share, By Dysfunction Type, By Value, 2023 (%)
Figure 178: Indonesia Age-related Vision Dysfunction Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 179: Rest of Asia Pacific Age-related Vision Dysfunction Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 180: Rest of Asia Pacific Age-related Vision Dysfunction Market Value, By Distribution Channel, 2023 (USD Million)
Figure 181: Rest of Asia Pacific Age-related Vision Dysfunction Market Share, By Drug, By Value, 2023 (%)
Figure 182: Rest of Asia Pacific Age-related Vision Dysfunction Market Share, By Dysfunction Type, By Value, 2023 (%)
Figure 183: Rest of Asia Pacific Age-related Vision Dysfunction Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 184: Middle East and Africa Age-related Vision Dysfunction Market Size, By Value, 2020H-2030F (USD Million)
Figure 185: Middle East and Africa Age-related Vision Dysfunction Market Share, By Dysfunction Type, 2023 (%)
Figure 186: Middle East and Africa Age-related Vision Dysfunction Market Share, By New Product Launches, 2023 (%)
Figure 187: Middle East and Africa Age-related Vision Dysfunction Market Share, By Company, 2023 (%)
Figure 188: Middle East and Africa Age-related Vision Dysfunction Market CAGR (%), By Region, 2020-2023, 2025-2030
Figure 189: Middle East and Africa Age-related Vision Dysfunction Market, By Eylea, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 190: Middle East and Africa Age-related Vision Dysfunction Market, By Lucentis, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 191: Middle East and Africa Age-related Vision Dysfunction Market, By Combigan, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 192: Middle East and Africa Age-related Vision Dysfunction Market, By Beovu, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 193: Middle East and Africa Age-related Vision Dysfunction Market, By Other Drugs, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 194: Middle East and Africa Age-related Vision Dysfunction Market, By Glaucoma, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 195: Middle East and Africa Age-related Vision Dysfunction Market, By Cataract, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 196: Middle East and Africa Age-related Vision Dysfunction Market, By Presbyopia, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 197: Middle East and Africa Age-related Vision Dysfunction Market, By AMD, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 198: Middle East and Africa Age-related Vision Dysfunction Market, By Online Pharmacies, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 199: Middle East and Africa Age-related Vision Dysfunction Market, By Retail Pharmacies , By Value, 2020H-2030F (USD Millions & CAGR)
Figure 200: GCC Age-related Vision Dysfunction Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 201: GCC Age-related Vision Dysfunction Market Value, By Distribution Channel, 2023 (USD Million)
Figure 202: GCC Age-related Vision Dysfunction Market Share, By Drug, By Value, 2023 (%)
Figure 203: GCC Age-related Vision Dysfunction Market Share, By Dysfunction Type, By Value, 2023 (%)
Figure 204: GCC Age-related Vision Dysfunction Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 205: Israel Age-related Vision Dysfunction Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 206: Israel Age-related Vision Dysfunction Market Value, By Distribution Channel, 2023 (USD Million)
Figure 207: Israel Age-related Vision Dysfunction Market Share, By Drug, By Value, 2023 (%)
Figure 208: Israel Age-related Vision Dysfunction Market Share, By Dysfunction Type, By Value, 2023 (%)
Figure 209: Israel Age-related Vision Dysfunction Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 210: South Africa Age-related Vision Dysfunction Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 211: South Africa Age-related Vision Dysfunction Market Value, By Distribution Channel, 2023 (USD Million)
Figure 212: South Africa Age-related Vision Dysfunction Market Share, By Drug, By Value, 2023 (%)
Figure 213: South Africa Age-related Vision Dysfunction Market Share, By Dysfunction Type, By Value, 2023 (%)
Figure 214: South Africa Age-related Vision Dysfunction Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 215: Rest of Middle East and Africa Age-related Vision Dysfunction Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 216: Rest of Middle East and Africa Age-related Vision Dysfunction Market Value, By Distribution Channel, 2023 (USD Million)
Figure 217: Rest of Middle East and Africa Age-related Vision Dysfunction Market Share, By Drug, By Value, 2023 (%)
Figure 218: Rest of Middle East and Africa Age-related Vision Dysfunction Market Share, By Dysfunction Type, By Value, 2023 (%)
Figure 219: Rest of Middle East and Africa Age-related Vision Dysfunction Market Share, By Distribution Channel, By Value, 2023 (%)
Figure 220: Market Share of Prominent Companies of Global Age-related Vision Dysfunction Market, 2023 (%)
List of Tables
Table A1: Global Impact of Macro Economic Factors, By Region
Table A2: United States Age-related Vision Dysfunction Market, By Drug, By Value, 2020-2023 (USD Million)
Table A3: United States Age-related Vision Dysfunction Market, By Drug, By Value, 2024-2030 (USD Million)
Table A4: United States Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2020-2023 (USD Million)
Table A5: United States Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2024-2030 (USD Million)
Table A6: United States Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A7: United States Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A8: Canada Age-related Vision Dysfunction Market, By Drug, By Value, 2020-2023 (USD Million)
Table A9: Canada Age-related Vision Dysfunction Market, By Drug, By Value, 2024- 2030 (USD Million)
Table A10: Canada Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2020-2023 (USD Million)
Table A11: Canada Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2024-2030 (USD Million)
Table A12: Canada Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A13: Canada Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A14: Brazil Age-related Vision Dysfunction Market, By Drug, By Value, 2020-2023 (USD Million)
Table A15: Brazil Age-related Vision Dysfunction Market, By Drug, By Value, 2024-2030 (USD Million)
Table A16: Brazil Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2020-2023 (USD Million)
Table A17: Brazil Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2024-2030 (USD Million)
Table A18: Brazil Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A19: Brazil Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A20: Mexico Age-related Vision Dysfunction Market, By Drug, By Value, 2020-2023 (USD Million)
Table A21: Mexico Age-related Vision Dysfunction Market, By Drug, By Value, 2024-2030 (USD Million)
Table A22: Mexico Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2020-2023 (USD Million)
Table A23: Mexico Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2024-2030 (USD Million)
Table A24: Mexico Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A25: Mexico Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A26: Rest of Americas Age-related Vision Dysfunction Market, By Drug, By Value, 2020-2023 (USD Million)
Table A27: Rest of Americas Age-related Vision Dysfunction Market, By Drug, By Value, 2024-2030 (USD Million)
Table A28: Rest of Americas Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2020-2023 (USD Million)
Table A29: Rest of Americas Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2024-2030 (USD Million)
Table A30: Rest of Americas Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A31: Rest of Americas Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A32: Russia Age-related Vision Dysfunction Market, By Drug, By Value, 2020-2023 (USD Million)
Table A33: Russia Age-related Vision Dysfunction Market, By Drug, By Value, 2024-2030 (USD Million)
Table A34: Russia Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2020-2023 (USD Million)
Table A35: Russia Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2024-2030 (USD Million)
Table A36: Russia Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A37: Russia Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A38: France Age-related Vision Dysfunction Market, By Drug, By Value, 2020-2023 (USD Million)
Table A39: France Age-related Vision Dysfunction Market, By Drug, By Value, 2024-2030 (USD Million)
Table A40: France Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2020-2023 (USD Million)
Table A41: France Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2024-2030 (USD Million)
Table A42: France Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A43: France Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A44: United Kingdom Age-related Vision Dysfunction Market, By Drug, By Value, 2020-2023 (USD Million)
Table A45: United Kingdom Age-related Vision Dysfunction Market, By Drug, By Value, 2024-2030 (USD Million)
Table A46: United Kingdom Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2020-2023 (USD Million)
Table A47: United Kingdom Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2024-2030 (USD Million)
Table A48: United Kingdom Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A49: United Kingdom Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A50: Germany Age-related Vision Dysfunction Market, By Drug, By Value, 2020-2023 (USD Million)
Table A51: Germany Age-related Vision Dysfunction Market, By Drug, By Value, 2024-2030 (USD Million)
Table A52: Germany Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2020-2023 (USD Million)
Table A53: Germany Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2024-2030 (USD Million)
Table A54: Germany Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A55: Germany Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A56: Italy Age-related Vision Dysfunction Market, By Drug, By Value, 2020-2023 (USD Million)
Table A57: Italy Age-related Vision Dysfunction Market, By Drug, By Value, 2024-2030 (USD Million)
Table A58: Italy Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2020-2023 (USD Million)
Table A59: Italy Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2024-2030 (USD Million)
Table A60: Italy Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A61: Italy Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A62: Spain Age-related Vision Dysfunction Market, By Drug, By Value, 2020-2023 (USD Million)
Table A63: Spain Age-related Vision Dysfunction Market, By Drug, By Value, 2024-2030 (USD Million)
Table A64: Spain Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2020-2023 (USD Million)
Table A65: Spain Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2024-2030 (USD Million)
Table A66: Spain Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A67: Spain Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A68: Turkey Age-related Vision Dysfunction Market, By Drug, By Value, 2020-2023 (USD Million)
Table A69: Turkey Age-related Vision Dysfunction Market, By Drug, By Value, 2024-2030 (USD Million)
Table A70: Turkey Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2020-2023 (USD Million)
Table A71: Turkey Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2024-2030 (USD Million)
Table A72: Turkey Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A73: Turkey Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A74: Rest of Europe Age-related Vision Dysfunction Market, By Drug, By Value, 2020-2023 (USD Million)
Table A75: Rest of Europe Age-related Vision Dysfunction Market, By Drug, By Value, 2024-2030 (USD Million)
Table A76: Rest of Europe Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2020-2023 (USD Million)
Table A77: Rest of Europe Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2024-2030 (USD Million)
Table A78: Rest of Europe Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A79: Rest of Europe Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A80: China Age-related Vision Dysfunction Market, By Drug, By Value, 2020-2023 (USD Million)
Table A81: China Age-related Vision Dysfunction Market, By Drug, By Value, 2024-2030 (USD Million)
Table A82: China Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2020-2023 (USD Million)
Table A83: China Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2024-2030 (USD Million)
Table A84: China Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A85: China Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A86: India Age-related Vision Dysfunction Market, By Drug, By Value, 2020-2023 (USD Million)
Table A87: India Age-related Vision Dysfunction Market, By Drug, By Value, 2024-2030 (USD Million)
Table A88: India Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2020-2023 (USD Million)
Table A89: India Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2024-2030 (USD Million)
Table A90: India Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A91: India Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A92: South Korea Age-related Vision Dysfunction Market, By Drug, By Value, 2020-2023 (USD Million)
Table A93: South Korea Age-related Vision Dysfunction Market, By Drug, By Value, 2024-2030 (USD Million)
Table A94: South Korea Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2020-2023 (USD Million)
Table A95: South Korea Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2024-2030 (USD Million)
Table A96: South Korea Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A97: South Korea Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A98: Japan Age-related Vision Dysfunction Market, By Drug, By Value, 2020-2023 (USD Million)
Table A99: Japan Age-related Vision Dysfunction Market, By Drug, By Value, 2024-2030 (USD Million)
Table A100: Japan Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2020-2023 (USD Million)
Table A101: Japan Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2024-2030 (USD Million)
Table A102: Japan Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A103: Japan Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A104: Singapore Age-related Vision Dysfunction Market, By Drug, By Value, 2020-2023 (USD Million)
Table A105: Singapore Age-related Vision Dysfunction Market, By Drug, By Value, 2024-2030 (USD Million)
Table A106: Singapore Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2020-2023 (USD Million)
Table A107: Singapore Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2024-2030 (USD Million)
Table A108: Singapore Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A109: Singapore Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A110: Indonesia Age-related Vision Dysfunction Market, By Drug, By Value, 2020-2023 (USD Million)
Table A111: Indonesia Age-related Vision Dysfunction Market, By Drug, By Value, 2024-2030 (USD Million)
Table A112: Indonesia Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2020-2023 (USD Million)
Table A113: Indonesia Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2024-2030 (USD Million)
Table A114: Indonesia Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A115: Indonesia Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A116: Rest of Asia Pacific Age-related Vision Dysfunction Market, By Drug, By Value, 2020-2023 (USD Million)
Table A117: Rest of Asia Pacific Age-related Vision Dysfunction Market, By Drug, By Value, 2024-2030 (USD Million)
Table A118: Rest of Asia Pacific Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2020-2023 (USD Million)
Table A119: Rest of Asia Pacific Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2024-2030 (USD Million)
Table A120: Rest of Asia Pacific Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A121: Rest of Asia Pacific Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A122: GCC Age-related Vision Dysfunction Market, By Drug, By Value, 2020-2023 (USD Million)
Table A123: GCC Age-related Vision Dysfunction Market, By Drug, By Value, 2024-2030 (USD Million)
Table A124: GCC Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2020-2023 (USD Million)
Table A125: GCC Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2024-2030 (USD Million)
Table A126: GCC Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A127: GCC Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A128: Israel Age-related Vision Dysfunction Market, By Drug, By Value, 2020-2023 (USD Million)
Table A129: Israel Age-related Vision Dysfunction Market, By Drug, By Value, 2024-2030 (USD Million)
Table A130: Israel Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2020-2023 (USD Million)
Table A131: Israel Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2024-2030 (USD Million)
Table A132: Israel Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A133: Israel Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A134: South Africa Age-related Vision Dysfunction Market, By Drug, By Value, 2020-2023 (USD Million)
Table A135: South Africa Age-related Vision Dysfunction Market, By Drug, By Value, 2024-2030 (USD Million)
Table A136: South Africa Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2020-2023 (USD Million)
Table A137: South Africa Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2024-2030 (USD Million)
Table A138: South Africa Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A139: South Africa Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A140: Rest of Middle East and Africa Age-related Vision Dysfunction Market, By Drug, By Value, 2020-2023 (USD Million)
Table A141: Rest of Middle East and Africa Age-related Vision Dysfunction Market, By Drug, By Value, 2024-2030 (USD Million)
Table A142: Rest of Middle East and Africa Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2020-2023 (USD Million)
Table A143: Rest of Middle East and Africa Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2024-2030 (USD Million)
Table A144: Rest of Middle East and Africa Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A145: Rest of Middle East and Africa Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A2: United States Age-related Vision Dysfunction Market, By Drug, By Value, 2020-2023 (USD Million)
Table A3: United States Age-related Vision Dysfunction Market, By Drug, By Value, 2024-2030 (USD Million)
Table A4: United States Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2020-2023 (USD Million)
Table A5: United States Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2024-2030 (USD Million)
Table A6: United States Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A7: United States Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A8: Canada Age-related Vision Dysfunction Market, By Drug, By Value, 2020-2023 (USD Million)
Table A9: Canada Age-related Vision Dysfunction Market, By Drug, By Value, 2024- 2030 (USD Million)
Table A10: Canada Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2020-2023 (USD Million)
Table A11: Canada Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2024-2030 (USD Million)
Table A12: Canada Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A13: Canada Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A14: Brazil Age-related Vision Dysfunction Market, By Drug, By Value, 2020-2023 (USD Million)
Table A15: Brazil Age-related Vision Dysfunction Market, By Drug, By Value, 2024-2030 (USD Million)
Table A16: Brazil Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2020-2023 (USD Million)
Table A17: Brazil Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2024-2030 (USD Million)
Table A18: Brazil Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A19: Brazil Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A20: Mexico Age-related Vision Dysfunction Market, By Drug, By Value, 2020-2023 (USD Million)
Table A21: Mexico Age-related Vision Dysfunction Market, By Drug, By Value, 2024-2030 (USD Million)
Table A22: Mexico Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2020-2023 (USD Million)
Table A23: Mexico Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2024-2030 (USD Million)
Table A24: Mexico Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A25: Mexico Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A26: Rest of Americas Age-related Vision Dysfunction Market, By Drug, By Value, 2020-2023 (USD Million)
Table A27: Rest of Americas Age-related Vision Dysfunction Market, By Drug, By Value, 2024-2030 (USD Million)
Table A28: Rest of Americas Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2020-2023 (USD Million)
Table A29: Rest of Americas Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2024-2030 (USD Million)
Table A30: Rest of Americas Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A31: Rest of Americas Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A32: Russia Age-related Vision Dysfunction Market, By Drug, By Value, 2020-2023 (USD Million)
Table A33: Russia Age-related Vision Dysfunction Market, By Drug, By Value, 2024-2030 (USD Million)
Table A34: Russia Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2020-2023 (USD Million)
Table A35: Russia Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2024-2030 (USD Million)
Table A36: Russia Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A37: Russia Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A38: France Age-related Vision Dysfunction Market, By Drug, By Value, 2020-2023 (USD Million)
Table A39: France Age-related Vision Dysfunction Market, By Drug, By Value, 2024-2030 (USD Million)
Table A40: France Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2020-2023 (USD Million)
Table A41: France Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2024-2030 (USD Million)
Table A42: France Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A43: France Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A44: United Kingdom Age-related Vision Dysfunction Market, By Drug, By Value, 2020-2023 (USD Million)
Table A45: United Kingdom Age-related Vision Dysfunction Market, By Drug, By Value, 2024-2030 (USD Million)
Table A46: United Kingdom Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2020-2023 (USD Million)
Table A47: United Kingdom Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2024-2030 (USD Million)
Table A48: United Kingdom Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A49: United Kingdom Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A50: Germany Age-related Vision Dysfunction Market, By Drug, By Value, 2020-2023 (USD Million)
Table A51: Germany Age-related Vision Dysfunction Market, By Drug, By Value, 2024-2030 (USD Million)
Table A52: Germany Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2020-2023 (USD Million)
Table A53: Germany Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2024-2030 (USD Million)
Table A54: Germany Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A55: Germany Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A56: Italy Age-related Vision Dysfunction Market, By Drug, By Value, 2020-2023 (USD Million)
Table A57: Italy Age-related Vision Dysfunction Market, By Drug, By Value, 2024-2030 (USD Million)
Table A58: Italy Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2020-2023 (USD Million)
Table A59: Italy Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2024-2030 (USD Million)
Table A60: Italy Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A61: Italy Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A62: Spain Age-related Vision Dysfunction Market, By Drug, By Value, 2020-2023 (USD Million)
Table A63: Spain Age-related Vision Dysfunction Market, By Drug, By Value, 2024-2030 (USD Million)
Table A64: Spain Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2020-2023 (USD Million)
Table A65: Spain Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2024-2030 (USD Million)
Table A66: Spain Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A67: Spain Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A68: Turkey Age-related Vision Dysfunction Market, By Drug, By Value, 2020-2023 (USD Million)
Table A69: Turkey Age-related Vision Dysfunction Market, By Drug, By Value, 2024-2030 (USD Million)
Table A70: Turkey Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2020-2023 (USD Million)
Table A71: Turkey Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2024-2030 (USD Million)
Table A72: Turkey Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A73: Turkey Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A74: Rest of Europe Age-related Vision Dysfunction Market, By Drug, By Value, 2020-2023 (USD Million)
Table A75: Rest of Europe Age-related Vision Dysfunction Market, By Drug, By Value, 2024-2030 (USD Million)
Table A76: Rest of Europe Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2020-2023 (USD Million)
Table A77: Rest of Europe Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2024-2030 (USD Million)
Table A78: Rest of Europe Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A79: Rest of Europe Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A80: China Age-related Vision Dysfunction Market, By Drug, By Value, 2020-2023 (USD Million)
Table A81: China Age-related Vision Dysfunction Market, By Drug, By Value, 2024-2030 (USD Million)
Table A82: China Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2020-2023 (USD Million)
Table A83: China Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2024-2030 (USD Million)
Table A84: China Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A85: China Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A86: India Age-related Vision Dysfunction Market, By Drug, By Value, 2020-2023 (USD Million)
Table A87: India Age-related Vision Dysfunction Market, By Drug, By Value, 2024-2030 (USD Million)
Table A88: India Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2020-2023 (USD Million)
Table A89: India Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2024-2030 (USD Million)
Table A90: India Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A91: India Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A92: South Korea Age-related Vision Dysfunction Market, By Drug, By Value, 2020-2023 (USD Million)
Table A93: South Korea Age-related Vision Dysfunction Market, By Drug, By Value, 2024-2030 (USD Million)
Table A94: South Korea Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2020-2023 (USD Million)
Table A95: South Korea Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2024-2030 (USD Million)
Table A96: South Korea Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A97: South Korea Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A98: Japan Age-related Vision Dysfunction Market, By Drug, By Value, 2020-2023 (USD Million)
Table A99: Japan Age-related Vision Dysfunction Market, By Drug, By Value, 2024-2030 (USD Million)
Table A100: Japan Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2020-2023 (USD Million)
Table A101: Japan Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2024-2030 (USD Million)
Table A102: Japan Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A103: Japan Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A104: Singapore Age-related Vision Dysfunction Market, By Drug, By Value, 2020-2023 (USD Million)
Table A105: Singapore Age-related Vision Dysfunction Market, By Drug, By Value, 2024-2030 (USD Million)
Table A106: Singapore Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2020-2023 (USD Million)
Table A107: Singapore Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2024-2030 (USD Million)
Table A108: Singapore Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A109: Singapore Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A110: Indonesia Age-related Vision Dysfunction Market, By Drug, By Value, 2020-2023 (USD Million)
Table A111: Indonesia Age-related Vision Dysfunction Market, By Drug, By Value, 2024-2030 (USD Million)
Table A112: Indonesia Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2020-2023 (USD Million)
Table A113: Indonesia Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2024-2030 (USD Million)
Table A114: Indonesia Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A115: Indonesia Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A116: Rest of Asia Pacific Age-related Vision Dysfunction Market, By Drug, By Value, 2020-2023 (USD Million)
Table A117: Rest of Asia Pacific Age-related Vision Dysfunction Market, By Drug, By Value, 2024-2030 (USD Million)
Table A118: Rest of Asia Pacific Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2020-2023 (USD Million)
Table A119: Rest of Asia Pacific Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2024-2030 (USD Million)
Table A120: Rest of Asia Pacific Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A121: Rest of Asia Pacific Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A122: GCC Age-related Vision Dysfunction Market, By Drug, By Value, 2020-2023 (USD Million)
Table A123: GCC Age-related Vision Dysfunction Market, By Drug, By Value, 2024-2030 (USD Million)
Table A124: GCC Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2020-2023 (USD Million)
Table A125: GCC Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2024-2030 (USD Million)
Table A126: GCC Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A127: GCC Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A128: Israel Age-related Vision Dysfunction Market, By Drug, By Value, 2020-2023 (USD Million)
Table A129: Israel Age-related Vision Dysfunction Market, By Drug, By Value, 2024-2030 (USD Million)
Table A130: Israel Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2020-2023 (USD Million)
Table A131: Israel Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2024-2030 (USD Million)
Table A132: Israel Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A133: Israel Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A134: South Africa Age-related Vision Dysfunction Market, By Drug, By Value, 2020-2023 (USD Million)
Table A135: South Africa Age-related Vision Dysfunction Market, By Drug, By Value, 2024-2030 (USD Million)
Table A136: South Africa Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2020-2023 (USD Million)
Table A137: South Africa Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2024-2030 (USD Million)
Table A138: South Africa Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A139: South Africa Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Table A140: Rest of Middle East and Africa Age-related Vision Dysfunction Market, By Drug, By Value, 2020-2023 (USD Million)
Table A141: Rest of Middle East and Africa Age-related Vision Dysfunction Market, By Drug, By Value, 2024-2030 (USD Million)
Table A142: Rest of Middle East and Africa Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2020-2023 (USD Million)
Table A143: Rest of Middle East and Africa Age-related Vision Dysfunction Market, By Dysfunction Type, By Value, 2024-2030 (USD Million)
Table A144: Rest of Middle East and Africa Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2020-2023 (USD Million)
Table A145: Rest of Middle East and Africa Age-related Vision Dysfunction Market, By Distribution Channel, By Value, 2024-2030 (USD Million)
Companies Mentioned
- Bausch + Lomb
- D Western Therapeutics Institute
- Novartis
- IVERIC Bio
- Santen Pharmaceutical
- AbbVie
- Aerie Pharmaceuticals
- Eyenovia
- Sun Pharma Advanced Research Company Limited
- Orasis Pharmaceuticals
